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ASSESSMENT OF EXECUTIVE FUNCTION IN TYPE 2 DIABETES 
MELLITUS – A CASE CONTROL STUDY 
Abstract 
Introduction: 
Type2 Diabetes Mellitus is associated with inherent micro-vascular disease affecting frontal 
sub-cortical function. Executive Dysfunctions are implicated in decreased self-care capacity, 
poor adherence to diabetic medication, decreased levels of autonomy and a decrease in ability 
to make essential decision, for instrumental activities of daily living, as well as resistance to 
proper medical care.Isolated executive impairment falls within the category of “mild 
cognitive impairment. Studies have shown that patients with Type 2 DM performs 
significantly poorer in Executive Function compared to normal subjects .Hence this study 
was proposed to assess the executive Function of Type 2 DM patients. 
Aim &Objective: 
To assess executive functioning in type 2 diabetic patients compared to normal subjects. 
Methods: 
The study is a cross sectional observational case control study,conducted  at the Rajiv Gandhi 
Government General Hospital(RGGGH), Chennai. 50 patients attending outpatient 
department of Diabetology, fulfilling the inclusion criteria were randomly chosen and 
included in the study. Fifty consenting age, sex, education matched normal people who were 
relatives of patients attending RGGGH OPD were taken as controls. Both the study 
population and controls were administered the semi structured proforma. Then GHQ and 
HAM D was administered to screen for psychiatric symptoms.  Those who scored positively 
were excluded from the study.  MMSE was administered as a screening tool for cognition. 
All diabetes mellitus patients were tested for their blood glucose level before administering 
the evaluation tests. This was done to avoid hypoglycemia /severe hyperglycemiaaffecting 
the executive function assessment. The following  parameters were assessed - Proforma for 
socio demographic data of study cases and control group, Proforma for Diabetes Status, Mini 
Mental State Examination (MMSE), Test for Executive Function namely Digit Span 
Test,Verbal fluency , Trail making test, Stroop  Test, Wisconsin Card Sorting Test. The data 
collected were analysed using Chi square test and Wilcoxon – Mann-Whitney U test. 
Result: 
Comparison of socio-demographic data of cases and controls shows no significant difference. 
The mean age of onset of diabetesmellitus is 41.40 years and the duration of illness was < 5 
years. There was no major macro / micro vascular complication. Comparison of 
neuropsychological scores between cases(study group) and controls with Digit Span 
Test,Verbal fluency , Trail making test, Stroop  Test, Wisconsin Card Sorting Test was 
done.In Digit Span Test,Verbal fluency, Stroop  Test& Wisconsin Card Sorting Test did not 
show statistical significance. Trail making test showed statistical significance. 
Conclusion: 
 Executive functioning in diabetics was comparable to that of control group. Though 
Trail making test, showed a statistical difference between diabetics and non-diabetic, it was 
still within the normative Range for the particular age group. Validation of this conclusion 
requires a larger group and prospective longitudinal study. 
Keywords : 
Executive function, Diabetes Mellitus, Stroop  Test, Wisconsin Card Sorting Test 
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INRODUCTION  
Diabetes  mell i tus  type 2 is  a  metabol ic  disorder  
character ized by hyperglycemia in  the  context  of  insul in  
res is tance and relat ive lack of  insul in1 ,  2 .Type 2  Diabetes  
Mell i tus  is  being descr ibed as  a  modern day epidemic,  
emerging rapidly in  developing countr ies1 .  Type2 diabetes  
mel l i tus  is  a  major  publ ic  heal th  problem al l  over  the  
world3 .  The socio-economic cost  of  Type 2 diabetes  
mel l i tus  is  exorbi tant ,  mainly due to  number  of  associated  
problems that  accompany diabetes  mel l i tus ,  l ike micro and 
macro vascular  diseases  and their  increased suscept ibi l i ty  
for  cogni t ive impairment1 , 2 .   
     Execut ive funct ion is  a  pr imary domain of  cogni t ion 
that  involves  a  broad set  of  cogni t ive abi l i t ies  l ike 
a t tent ion,  working memory,  organizat ion,  and pers is tence 
that  are  necessary for  orchestrat ing complex,  goal-directed  
act ivi t ies3 .  Execut ive funct ion appears  to  be orchestrated  
and mediated by frontal  cor tex along with i ts  networks in  
cerebrum and sub-cort ical  regions of  brain4 .Though i t  i s  
known that  diabetes  is  re lated to  some domains  of  
cogni t ion such as  processing speed and memory,  greater  
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a t tent ion is  now being directed to  the associat ion and 
causal  l ink between diabetes  and execut ive funct ioning 
domain of  cogni t ion1 , 5 .  Recent  s tudies  and evolving data  
categorical ly  suggest  that  execut ive dysfunct ion is  
causat ively associated with poor  glycemic control2 , 5  i .e .  i t  
i s  one of  the major  r isk factor .  The effect  of  Type2 
diabetes  mel l i tus  on execut ive funct ion is  associated wi th 
inherent  micro-vascular  disease affect ing frontal   
sub-cort ical  funct ion1 .  
Execut ive funct ion is  a  major  domain of  cogni t ion 
that  plays  a  pivotal  role  in  a l lowing the execut ion of  dai ly  
management  tasks  including exercise ,  b lood glucose 
monitor ing and drug intake,  which are  essent ial  for  
glycemic control1 .  Execut ive Dysfunct ions are  implicated  
in  decreased self  care  capaci ty ,  poor  adherence to  diabet ic  
medicat ion,  decreased levels  of  autonomy and a  decrease 
in  abi l i ty  to  make essent ia l  decis ion,  for  instrumental  
act ivi t ies  of  dai ly  l iving,  as  wel l  as  res is tance to  proper  
medical  care1 , 5 .  Individuals  with  Type2 diabetes  mell i tus  
perform signif icant ly  poorer  in  execut ive funct ional  
measures  compared to  normal  adul ts .  
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The purpose of  this  s tudy is  to  assess  execut ive 
funct ion in  pat ients  with type 2 Diabetes  mel l i tus  in  
comparison to  normal  subjects .  
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REVIEW OF LITERATURE 
EXECUTIVE FUNCTION 
DEFINITION:  
In  this  modern world with  a  f requent ly  changing  
environment ,  we are  constant ly  facing al tered 
ci rcumstances  that  require ,  cont inuous generat ion and 
credible  monitor ing of  appropriate  s t rategies ,  for  which 
newer  ways of  act ion have to  be  formulated and 
conducted 3 .  
 The specif ic  abi l i t ies  that  are  cal led upon to  respond 
accurately  to  newer  s i tuat ions  are  referred to  as  Execut ive 
Funct ions.  This  domain of  cogni t ive funct ions  is  used for  
usual ly  managing the condit ions  in  which rout ine 
act ivat ion of  behavior  would not  be suff ic ient  for  opt imal  
performance,  and hence in  those condi t ions a  top-down 
control  is  required to  adjust  or  modify behavior 4 .   
The Diagnost ic  and Stat is t ical  Manuel  of  Mental  
Disorders ,  four th  edi t ion,  def ines  execut ive funct ion as  
one’s  abi l i ty  to  plan ,  ini t ia te ,  sequence,  monitor  and 
inhibi t  complex goal  directed behavior3 .   
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Execut ive funct ion is  a  set  of  cogni t ive  process  that  
a l lows one to  behave independent  of  the environment ,  
instead of  having behaviors  mediated  by the environment4 .   
Psychodynamic Diagnost ic  Manual  –  def ines  
execut ive funct ion as  cogni t ive abi l i t ies  necessary for  
complex goal  directed behavior and adaptat ion to  a  range 
of  environmental  changes and demands.  Funct ions include 
the abi l i ty  to  plan and ant ic ipate  outcomes (cogni t ive  
f lexibi l i ty) ,  the  abi l i ty  to  direct  a t tent ional  resources  to  
meet  the  demands of  non-rout ine events .  
     American psychiatr ic  associat ion descr ibes  execut ive 
funct ion as  a  set  of  cogni t ive abi l i t ies  that  control  and 
regulate  other  abi l i t ies  and behaviors .  They include abi l i ty  
to  ini t ia te  and s top act ions,  to  monitor  and change 
behavior  as  needed,  and to  plan  future  behavior  when faced 
with  novel  task  and s i tuat ion3 .  
Two central  themes of  execut ive control  f ramework are4  
Self  regulatory  ski l ls   
 Percept ion 
 Modulat ion 
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 Sustained at tent ion 
 Flexibi l i ty  
 Working memory 
 Response inhibi t ion 
 Emotional  regulat ion 
Goal  or iented  ski l ls  
 Planning 
 Organizat ion 
 Time management  
 Self  monitor ing 
Execut ive funct ions comprise  a  set  of  ski l ls  which are  
responsible  for  orchestrat ing goal  or iented act ivi t ies  l ike  
f inances,  medicat ions,  t ransporta t ion,  shopping,  cooking,  
housework,  and using mult imedia  and communicat ion 
devices4 , 5 .   
These act ivi t ies  const i tu te  the Instrumental  Act iv i t ies  
of  Dai ly  Living4 .These act ivi t ies  are  made possible  
through successful  planning,  ini t ia t ion,  sequencing with 
ongoing monitor ing and assessment  for  possible  
adjustments  of  goals  or  act ions .  Similar  to  other  cogni t ive  
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funct ions,  such as  language and memory,  these are  
acquired  ski l ls .  Intact  execut ive funct ions are  thus vi ta l  to  
human autonomy 4.  
Anatomical ly ,  the pre-f rontal  cortex and i ts  basal  
gangl ia  connect ions are  responsible  for  execut ive 
funct ioning2 .  I t  i s  however  diff icul t  to  exact ly  local ize  or  
pinpoint  specif ic  execut ive funct ions to  specif ic  areas  
within the frontal  cor tex.  The frontal  cor tex is  connected 
to  the caudate ,  putamen,  pal l idum and thalamus via  
c ircui ts 2 .  These connect ions are  intr insical ly  and 
dynamical ly  balanced direct  and indirect  c i rcui ts .  The 
importance of  these connect ions is  manifested by the fact  
that  execut ive impairment  may occur  without  direct  f rontal  
damage,  that  is  by disrupt ion of  these  dynamic ci rcui ts 2 , 6 .  
Isolated  execut ive impairment  fa l ls  within  the 
category of  “mild  cogni t ive  impairment” .  Mild cogni t ive 
impairment  is  heterogeneous group of  disorders6  which 
does  not  meet  the  cr i ter ia  for  dementia .  Execut ive 
impairment  was added to  the def ini t ion of  dement ia  by the 
American Psychiatr ic  Associat ion in  1994 7 .  
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The introduct ion of  diagnosis  –  Mild Neurocogni t ive 
disorder  is  crucial  change in  diagnost ic  cr i ter ia  for  
neurocogni t ive disorder  in  DSM – V Individuals  of ten seek 
medical  and psychiatr ic  evaluat ion for  neurocogni t ive 
problems that  do not  meet  the cr i ter ia  for  major  
neurocogni t ive disorder .  
DSM – V also includes complex at tent ion,  Execut ive  
funct ion,  per ipheral  motor  problems,  and social  cogni t ion 
among neurocogni t ive domains  that  can be impaired by a  
neurocogni t ive disorder .  
These individuals  f requent ly  fa l l  below the normal  
range of  funct ion on neuro-psychological  tes t ing,  but  thei r  
s igns  and symptoms are  not  severe  enough to  be c lass i f ied 
as  major  neurocogni t ive  disorder  or  dementia .  
Al though they may be l iving independent ly ,  they  
s t ruggle  with  act ivi t ies  of  dai ly  l iving and express  this  
diff icul ty .  Mild Neurocogni t ive  Impairment  is  of ten found 
to  be a  t ransi t ional  s tage between aging and dement ia .  
Al though Mild Neurocogni t ive  Impairment  can present  
with a  var ie ty  of  symptoms,  when memory loss  is  the 
predominant  symptom i t  is  termed as  Amnesic  Mild  
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Neurocogni t ive Impairment ,  and is  f requent ly  seen as  
Prodromal  s tage of  Alzheimer’s  dementia .  
When Individuals  have impairment  in  domains  other  
than memory,  i t  i s  c lassif ied  as  Non Amnesic ,  s ingle  or  
mult iple  domain Mild Neurocogni t ive  Impairment  and the 
individuals  are  more l ikely to  convert  to  other  dement ia .  
IMPACT OF EXECUTIVE IMPAIRMENT ON THE 
INDIVIDUAL: 
Execut ive impairment  has  been shown to be s t rongly 
associated to  a  number  of  chronic medical  diseases 1 ,  2 , 7 .  
More commonly associated condi t ions include 
schizophrenia ,  major  depressive disorders ,  chronic  
obstruct ive a i rway disease,  obstruct ive s leep apnea 
syndrome,  congest ive hear t  fa i lure ,  infect ion with  Human 
Immunodeficiency Virus,  chronic  renal  fa i lure ,  lung 
cancers ,  hypertension,  subcort ical  ischemic vascular  
disease,  pi tui tary  tumors and type 2 diabetes  mell i tus1 , 2 , 7 .  
During the normal  aging process  deter iorat ion of  
execut ive funct ion correla tes  with  longi tudinal  decl ine in  
funct ional  s ta tus ,  and thus may be considered a  predictor  
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of  funct ional  s ta tus .  Freedom House Study7  showed that  in  
pat ients  with  chronic  diseases  execut ive dysfunct ion may 
be viewed as  a  predictor  of  sever i ty  and disabi l i ty .  
Tests  of  execut ive funct ion correlate  s t rongly with  
instrumental  act ivi t ies  of  dai ly  l iving ra ther  than physical  
act ivi t ies  of  dai ly  l iving8 .  Execut ive funct ioning is  able  to  
discr iminate  between independent  pat ients ,  pat ients  
requir ing moderate  level  supervis ion and those requir ing 
ful l  supervis ion1 ,  there  by a  guiding in  level  of  supervis ion 
required.  
Self-management  is  regarded as  a  set  of  ski l led  
behaviors  used to  manage one’s  i l lness .  This  places  greater  
responsibi l i ty  on the individual  for  disease management .  
Execut ive impairment  impacts  negat ively on a  pat ients’  
abi l i ty  to  self-manage their  d isease.  I t  hinders  their  abi l i ty  
to  adhere  to  t reatment  regimens and implement  necessary 
l i fes tyle  changes.  These pat ients  have also been found to  
be much more resis tant  towards  effect ive care  and suffer  
f rom impaired  medical-decis ion-making capaci ty 8 , 9 .  
Pat ients  with execut ive impairment  are  less  l ikely to  
self - report  their  impairment  and /  or  di f f icul ty  than those 
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with memory impairment ,  and more frequent ly  may report  
i t  as  memory loss  rather  than execut ive dysfunct ion.  
However  impaired execut ive funct ion may have a  more 
profound effect  on ones  autonomy than impaired   
memory1 ,  1 0 ,  1 1 .  
TYPE 2 DIABETES MELLITUS AND COGNITION: 
DEFINITION: 
According to  WHO, the term diabetes  mell i tus  
descr ibes  a  metabol ic  disorder  of  mult iple  e t iology,  
character ized by chronic  hyperglycemia,  with  dis turbance 
of  carbohydrate ,  fa t  and protein  metabol ism,  resul t ing from 
defects  in  insul in  secret ion,  insul in  act ion,  or  both1 3 .  Type 
2 diabetes  mel l i tus  is  a  non-autoimmune,  complex,  
heterogeneous and polygenic  metabol ic  disease condi t ion 
in  which the body fai ls  to  produce enough insul in ,  
character ized by abnormal  glucose homeostas is1 4 .  
Diabetes  mell i tus  may present  with  character is t ic  
symptoms such as  thirs t ,  polyuria ,  b lurr ing of  vis ion and 
weight  loss .  In  i ts  severe  forms,  ketoacidosis  or  a  non-
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ketot ic  hyperosmolar  s ta te  may develop and lead to  s tupor ,  
coma and in  absence of  effect ive t reatment ,  death.  
Type 2  diabetes  mell i tus  is  associated with a  relat ive  
impairment  in  insul in  secret ion coupled with varying 
degrees  of  per ipheral  res is tance to  the act ion of  insul in .  
Type 2 diabetes  may also be considered a  syndrome with  
mult iple  associated co-morbidi t ies  and complicat ions 1 5 .  
The associated insul in resis tan t  s ta te  of  type2 diabetes  i s  
fundamental  to  the pathogenesis  of  the  metabol ic  
syndrome1 0 .  
The long term effects  of  diabetes  mell i tus  include  
ret inopathy with potent ia l  bl indness ,  nephropathy that  may 
lead to  renal  fa i lure ,  and/or  neuropathy with r isk of  foot  
ulcer ,  amputat ion,  Charcot  joints ,  and features  of  
autonomic dysfunct ion,  including sexual  dysfunct ion.  
People with  diabetes  mell i tus  are  at  increased of  
cardiovascular ,  per ipheral  vascular  and cerebrovascular  
disease1 6 .  
Diabetes  is  the potent ial  epidemic in  India  with more 
than 62 mil l ion diabet ic  individuals  current ly  diagnosed 
with the disease. 1 7 , 1 8 , 1 9  I t  i s  es t imated that  by 2030 
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diabetes  mell i tus  may aff l ic t  up to  79.4 mil l ion people  in  
India1 9 .  
GLOBAL BURDEN OF TYPE 2 DIABETES MELLITUS: 
Internat ional  Diabetes  federat ion has  reported  that  the 
prevalence of  Type 2 diabetes  mel l i tus  have reached  
epidemic proport ions a l l  over  the world.  Est imated number  
of  Type 2 Diabetes  mel l i tus  in  the year  2010 was around 
2,850,000 in  7  regions of  Internat ional  Diabetes  
Foundat ion.  The Internat ional  Diabetes  Foundat ion had 
est imated that  around 3,900,000 deaths  were caused by 
diabetes  in  2010 which is  about  6 .8  percent  of  the  tota l  
number  of  death global ly2 0 .  I t  is  es t imated that  by the year  
2030,  more than 75.5 percent  of  the  tota l  global  populat ion 
with diabetes  wil l  be the inhabi tants  of  the developing 
world countr ies  and the countr ies  expected to  be with 
largest  populat ion of  Type 2 diabetes  mel l i tus  in  the world 
are     1 . India(79.4%),  2 .China(42.3%),3.United  States  of  
America(30.3%) 2 1 .   
In  developing countr ies ,  the  major  proport ion of  
adul ts  pat ients  with Type 2 diabetes  mel l i tus  are  between 
45 years  and 64 years  of  age,  whi le  in  the developed  
 
 14
countr ies ,  most  of  the Type 2 Diabetes  Mell i tus  pat ients  
are  65 years  of  age and above.  The Internat ional  Diabetes  
Federat ion est imates  that  23,000,000 years  of  product ive 
l i fe  span are  lost  to  disabi l i ty  as  wel l  as  reduced qual i ty  of  
l i fe ,  as  a  direct  impact  of  the complicat ion associated wi th 
Type2 diabetes  mell i tus2 0 .  
Diabetes  is  a  complex disease that  requires  intensive  
self-care.  The execut ive funct ion seems to  be essent ia l  to  
carry out  the day to  day management  tasks  including 
exercise ,  blood glucose monitor ing and drug intake,  which 
are  pre-requis i te  for  adequate g lycemic control .  
Impairments  in  execut ive funct ional  abi l i ty  leads to  
reduct ion in  self -care  capaci ty ,  as  wel l  as  poor  adherence 
to  the essent ial  diabet ic  medicat ion,  low independence.  
Execut ive dysfunct ion is  a lso  responsible  for  their  
inabi l i ty  to  make appropriate  decis ions ,  low autonomy in 
instrumental  act ivi t ies  of  dai ly  l iving,  as  wel l  as  
reluctance to  care.  Type 2  d iabetes  mell i tus  pat ients  
perform signif icant ly  worse on execut ive funct ional  
measures  re la t ive to  normal  comparison adul t  
populat ion1 0 . 1 1 .  
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DIAGNOSIS OF TYPE 2 DIABETES MELLITUS: 
AMERICAN DIABETES ASSOCIATION CRITERIA 
DIAGNOSIS OF DIABETES MELLITUS2 2 :  
The American Diabetes  Associat ion (Diabetes  Care  
28:S4-S36,  2005)  s ta ted that  diabetes  can be provis ional ly  
diagnosed using any 1 of  the  fol lowing 3 cr i ter ia .   
1 .   Fast ing plasma glucose >126 mg/dl  (af ter  ni l  in take 
for  a t  least  e ight  hours)   
2 .   Casual  plasma glucose >200 mg/dl  ( taken randomly at  
any t ime of  day)  and associated diabetes  mell i tus  
symptoms:  
Polyphagia ,  polydipsia ,  polyuria  and unexplained  
weight  loss  of  more than 10% 
3.   Oral  glucose tolerance tes t  (GTT) (seventy f ive grams 
dose)  >200 mg/dl  for  the  2  hour  blood sample.  GTT is  
unnecessary i f  pat ient’s  FPG is  >126 mg/dl .  
The American Diabetes  Associat ion prefers  the 
fas t ing plasma glucose compared to  GTT for  diagnosing 
Diabetes  mell i tus .  
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IMPACT OF TYPE 2 DIABETES ON COGNITION: 
       Diabetes  mell i tus  is  recognized to  be associated with  
cogni t ive dysfunct ion and cogni t ive abnormali t ies 2 3 , 2 4 .  
Neuropsychological  tes ts  have demonstrated def ic i ts  in  
var ious aspects  of  cognit ion in  both young and elder ly  
diabet ics2 3 .  Defici ts  affect  global  cogni t ion,  psychomotor  
eff ic iency,  episodic  memory,  semantic  memory and 
working memory2 4 , 2 5 .  Cogni t ive decrements  may occur  a t  
two separate  intervals  of  cogni t ive vulnerabi l i ty :  
1 .   During brain development ,  ages  5-7 years ,  typical ly  
this  would refer  to  type 1 diabetes .  
2 .   Later  on they may develop within the 
neurodegenerat ive phase,  general ly  from age 65 years  
onwards.  This  would be accounted for  in  the major i ty  
by type 2 diabetes .  Outside of  these two per iods i t  
would need to  occur  in  the face of  both micro-
vascular  and macro-vascular  target  organ damage2 6 .  
Diabetes  mell i tus  is  a  r isk  factor  for  neurological  
condi t ions of  ageing;  these include al l  forms of  dement ia  
and cogni t ive decl ine2 7 .  The impact  of  diabetes  mell i tus  on 
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cogni t ion has  been of  interest  for  a t  least  past  8  decades.  I t  
was f i rs t  explored by Miles  and Root  who demonstrated  
impaired memory,  poor  mental  ar i thmetic ,  and s lowed 
psychomotor  eff ic iency in  type 1 diabet ics  exclusively.  
They hypothesized that  the  main underlying mechanism 
might  be recurrent  hypoglycemic episodes.  However  this  
was disputed when la ter  cogni t ive impairment  was a lso 
s ignif icant ly  associated with type 2 diabet ics ,  in  whom 
chronic  hyperglycemia was thought  to  be responsible 1 2 .  
STUDIES SHOWING SIGNIFICANT CORRELATIONS:  
In  a  cross-sect ional  s tudy of  28 pat ients  with diabetes  
and 28 non-diabet ic  controls ,  Dey et  a l  (1997)  found some 
associat ion between cogni t ive impairment  in  people  with  
diabetes  aged 55 years  and younger .  When comparing 
people  with Type 2 diabetes  and people  without  the  
condi t ion,  Grimley Evans and Areosa Sastre  (2003)  found 
an up to  twofold increase in  the r isk of  cogni t ive 
impairment  or  dement ia  in  people with d iabetes 2 8 .  
Kumari  and Marmot  (2005) ,  in  a  prospect ive cohort  
s tudy of  4020 men and 1627 women (mean age 56 years)  
comparing cogni t ive performance in  three groups – those 
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with diabetes ,  impaired glucose tolerance,  and  
normoglycemia,  concluded that  type 2 diabetes  was  
associated with  impairment  some aspects  of  cogni t ion,  
par t icular ly  verbal  and mathematical  reasoning,  in  middle-
aged men and women3 2 .   
Kuo et  a l  in  20053 4  evaluated 2,802 community  
dwell ing aged adul ts  (of  which 358 had diabetes)  for  
cogni t ion and physical  funct ion,  a long with their  s ta tus  of  
act ivi ty  of  dai ly  l iving.  He reported  that  there  is  a  
s tas t is t ical ly  s ignif icant  increased rate  of  decl ine in  
performance on an execut ive funct ion of  a t tent ion in  those 
with diabetes  mell i tus  than in  people  without  diabetes  
mell i tus .  This  decl ine in  execut ive measure of  a t tent ion 
had a  compounded match of  a  increased rate of  decrease in  
performance on the physical  funct ion par t  of  the Medical  
Outcomes Study Heal th  Survey (SF-36)  quest ionnaire .  A 
s imilar  resul t  was found by measures  of  Act ivi t ies  of  Dai ly  
Living funct ioning assessing works/ jobs -  meal  
preparat ion,  homework,  f inance and heal th  management ,  
te lecommunicat ion use,  shopping,  and t ravel l ing.  
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Arvani takis  e t  a l  (2006) ,  in  the  Rush Memory and 
Aging Project ,  a  longi tudinal  c l inical  pathological  s tudy 
that  recrui ted 882 par t ic ipants  aged 80.5 (± 6.9  years)  f rom 
ret i rement  faci l i t ies  in  Chicago,  assessed episodic ,  
semantic ,  working memory,  perceptual  speed,  visuospat ia l  
abi l i ty  and global  cogni t ion and concluded that  diabetes  is  
associated with  lower levels  of  semantic  memory and 
perceptual  speed.  Associat ions were reduced when 
control l ing for  several  vascular  var iables  and were 
substant ia l ly  s t ronger  in  current  smokers2 9 , 3 0 .  
Many researchers  have reported impaired  performance 
on a  number  of  execut ive funct ion requir ing tasks  in  older  
adul ts  with type 2 Diabetes  Mell i tus .  Many longi tudinal  
invest igat ions of  type 2 Diabetes  Mell i tus  and cogni t ion 
had shown a s ignif icant ly  increased r isk of  execut ive 
funct ion decl ine5 2 .  Qiu WQ et  a l  in20063 5  assessed the  
cogni t ive funct ion of  291 people  older  than s ixty years  of  
age and who were home bound.  He found that  people  with 
type 2 diabetes  mel l i tus  (115),  demonstrated s ignif icant ly  
more def ic i ts  inn execut ive funct ion measures  -  updat ing 
or  working memory(7%),  reasoning(17%),  and in  
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shif t ing(21%).  These f indings were consis tent  wi th  other  
longi tudinal  datas  descr ibing a  smal l  and s ignif icant  
def ic i ts  over  basel ine of  approximately –10 percentage—in 
measures  of  a t tent ion (55)  and shif t ing (682)  in  older  
adul ts  who had type 2 Diabetes  mel l i tus .  A longi tudinal  
fol low-up showed that  these people with diabetes  mell i tus  
had two fold increase in  the r isk of  decl ine on both these 
measures  of  execut ive funct ion,  over  four  year  and s ix  year  
per iods.  
One of  the s t rongest  evidence for  type 2 diabetes  
mell i tus  causing execut ive dysfunct ion ar ises  f rom an  
analysis  by Yeung eta l (2009)3 6  .He administered  
mult id imensional  execut ive  funct ion assessment  bat tery  to  
465 older  adul ts ,  of  which 41 had type 2 Diabetes  Mell i tus .  
Those without  diabetes  mel l i tus  scored up-to  12% and 14% 
higher  than those with diabetes  on execut ive funct ion 
measures  of  inhibi t ion and shif t ing.  This  type of  
detr imental  effect  of  diabetes  mell i tus  on execut ive  
funct ion cont inued to  remain s ignif icant  even af ter  the  
s tudy sample was divided into  two groups –   
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1.  young-old (53–70 yrs)   
2 .  o ld-old (71–90 years) ,   
There by suggest ing that  the  impairments  were more 
l ikely to  be mediated by diabetes  mell i tus  s ta tus  of  the  
pat ient ,  ra ther  than by age of  the pat ient  
Alvarenga et  a l  in  20103 7  compared the funct ional  
mobil i ty ,  the  r isk of  fa l ls  and the execut ive funct ion 
among elder ly  with  and without  type 2 diabetes .  They 
concluded that  diabet ics  presented worse performance in  
the funct ional  mobil i ty  and in  the verbal  f luency test  than 
non-diabet ics  e lder ly  that  suggests  a  greater  r isk of  fa l ls  
for  the  e lder ly  with diabetes .  
Rucker  JR,  Jernigan SDamong etal  in  20113 8  did  the  
one of  the f i rs t  pi lot  s tudy to  examine execut ive abi l i t ies  
in  adul ts  wi th diabetes  across  a  range of  EF domains .  They 
found diabet ic  individuals  demonstra ted intact  performance 
on many measures ,  they appear  to  exhibi t  def ic i ts  in  
execut ive tasks  involving verbal  f luency and organizat ion ,  
perceptual  organizat ion and planning,  and t ime shar ing.  
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Similar ly ,  Nooyens et  a l  (2010)  measured cogni t ive  
funct ioning in  diabet ic  and non-diabet ic  adul ts  aged 43-70,  
twice in  a  5  year  interval  and found that  those pat ients  
with type 2 diabetes  mel l i tus  showed a  greater  decrease in 
cogni t ive funct ional  measures  than those individuals  
without  diabetes  mel l i tus3 3 .   
I t  i s  not  easy to  measure cogni t ive impairment  in  
diabetes  direct ly  given diabetes’  associat ion with  other  
r isk factors  such as  hypertension and dysl ipidemia,  and 
other  comorbidi t ies  including cardiovascular  disease,  a l l  of  
which have been shown to  interact  with cogni t ion 
(Perlmuter  e t  a l .  19885 1 ;  Larkin 20015 8  Messier  et  a l .  
20044 9 , 5 0  Van Den Berg et  a l .  20106 0) .  
Solanki  e ta l  in  2010 s tudied the associat ion of  
diabetes  mell i tus  wi th cogni t ive  funct ioning and 
depressive features  in  50 diabet ic  and 30 control  subjects ,  
and concluded that  though genesis  of  cogni t ive def ic i ts  in  
diabet ic  pat ients  is  complex,  i t  may be associated with  
chronical ly  poorly control led diabetes 4 4 .   
 Mukherjee  e t  a l  in  20124 5  determined the re la t ionship 
between diabetes  and cogni t ive impairment  is  respect  of  
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the age of  onset  and durat ion of  diabetes ,  other  
complicat ion of  diabetes  mel l i tus  and effect  of  short  term 
glycemic control  on cogni t ive impairment .  50 diabet ic  
pat ients  were assessed by ―Kolkata  Cognit ive Screening 
Bat tery.  They found that  cogni t ive  decl ine was associated  
with  diabetes  but  not  direct ly  re la ted to  the durat ion and 
age of  onset  of  diabetes  and control  of  diabetes  lead to  
improvement  of  cogni t ive  funct ion.  
Subha et  a l  in  2012 evaluated the cogni t ive  funct ional  
s ta tus  of  type 2 diabetes  mel l i tus  pat ients  and non-diabetes  
controls  using the Mini  Mental  Status  Examinat ion and the 
Modif ied Mini  Mental  Status  Examinat ion .  They 
concluded that  type 2 d iabetes  mel l i tus  is  associated with  
lesser  levels  of  performance of  cogni t ive funct ion4 6 .  
H.  Nicolae,  C.  Panea eta l  in  2012 5 9  assessed cogni t ive  
funct ion of  a  group of  23 type 2 diabetes  mel l i tus  pat ients  
who were between 40 and 68 years  of  age.  The global  
cogni t ive score  for  diabet ic  pat ients  was s ignif icant ly  low 
– 60.3/100 pts  when compared to  control  group -  69.08/100 
pts  (p  0 .048) .  The cogni t ive f ie ld  most  affected in  these 
pat ients  was the execut ive funct ion 7.30/20 points  in  
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diabet ic  pat ients  compared to  that  of  the control  group – 
11.04/20 points(p = 0.008) .  Thei r  inference was that  type 2 
Diabetes  Mell i tus  pat ients  had a  lower  cogni t ive score ,  
even at  middle-age,  when compared with pat ients  without  
this  type of  diabetes  mell i tus .  The concluded that  domain  
that  i s  more affected than other  domains  of  cogni t ion is  the  
execut ive funct ion.  
Marzieh Nazaribadie  e t  a l  in  2014 4 7  assessed the 
execut ive funct ions  and information processing in  type 2 
diabetes  mel l i tus  pat ients  in  comparison to pre-diabetes  
pat ients  and normal  subjects .  Execut ive funct ions were 
assessed by Wisconsin Card Sort ing Test  in  28 diabet ic  s ,  
28 prediabet ics  and 30 controls .  The pairwise comparisons  
of  execut ive funct ions among three groups suggest  a  
s ignif icant  difference between diabet ic  and normal  groups 
in  Wisconsin Card Sort ing Test  (perseverat ion)  p  = 0.018,  
and s ignif icant  dif ference between diabet ic  and pre-
diabet ic  pat ient  in  Wisconsin Card Sort ing Test  
(perseverat ion)  p  = 0.019.  They concluded that  there were 
s ignif icant  dif ferences  in  execut ive funct ion and 
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information processing in  pat ients  with  in  type 2 diabetes  
mel l i tus  and normal  individuals .  
STUDIES SHOWING INSIGNIFICANT 
CORRELATIONS:  
Deborah Amanda Goh et  a l  in  20144 8did a  pi lot  s tudy,  
to  evaluate the cl inical  associat ion between level  cogni t ive 
impairment  and the biochemical  per turbat ions that  occur  in  
Type 2Diabetes  Mel l i tus ,  and the impact  of  HMG Co A 
Reductase inhibi tors  (s ta t ins)  t reatment  on cogni t ive 
funct ion in  Type 2 diabetes  mell i tus  pat ients .  They 
concluded that  overal l  cognit ive  funct ion was s imilar  
among diabetes  mel l i tus  pat ients  and non-diabetes  
controls .  Among diabetes  mel l i tus  pat ient  wi th  HMG-CoA 
reductase inhibi tors  users ,  High Densi ty  Lipoproteins ,  Low 
Densi ty  Lipoproteins  and total  cholesterol  had a  negat ive 
correlat ion with  execut ive funct ion,  whereas per ipheral  
levels  of  insul in  and insul in  res is tance had a  negat ive 
correlat ion with  at tent ion.  Diabetes  mel l i tus  pat ient  with  
HMG-CoA reductase inhibi tors  users  were expected to  
have a  decreased level  performance in  the areas  of  
a t tent ion and execut ive funct ion.  Elevated levels  of  the  
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biomarkers  are  a lso expected to  contr ibute  to  poorer  
cogni t ive performance.  
Depression,  which has  been shown to  be more 
common in people wi th diabetes  than thei r  heal thy 
counterpar ts  (Amato et  a l .  19963 9 ;  Moussavi  e t  a l .  200741;  
Anderson et  a l .  20124 0 ; ) ,  can exacerbate  or  be mistaken for  
cogni t ive impairment  or  even the ear ly  s tages of  dementia  
(Visser  e t  a l .  20004 2 ;  Swainson et  a l .  20014 3) .  Many 
s tudies  have looked at  cognit ion,  but  of ten have taken  
global  measures  of  cogni t ive funct ion.  This  approach may 
overlook types  of  cogni t ive impairment  that  affect  specif ic  
areas  of  funct ion but  not  others .  Also,  s tudies  that  have 
looked at  specif ic  areas  of  cogni t ion have been extremely  
var ied in  their  s tudy designs and par t ic ipants  selected.   
The effect  of  type 2 diabetes  mell i tus  on execut ive  
funct ion had not  been demonstrated  consis tent ly  and 
uniformly across  a l l  s tudies .  Many Authors  have shown a  
negat ive correlat ion between diabetes  mel l i tus  and 
execut ive dysfunct ion.  
Lynnp.  Lowe et  a l  in  19945 4  explored the relat ionship  
between type II  diabetes  and cogni t ive funct ion in  80 
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diabet ic  and 81 non-diabet ic  older  Nat ive Americans and 
assessed the ef fects  of  other  selected  r isk factors  for  
cogni t ive dysfunct ion on this  re la t ionship.  They found 
l i t t le  evidence that  type II  diabetes  in  this  populat ion of  
Nat ive Americans was  associated wi th decrement  in  
cogni t ive funct ion.  Saczynski  JS eta l  in  20085 5  evaluated 
1,917 old aged people  (218 had type 2 Diabetes  mel l i tus)  
for  execut ive dysfunct ion and found that  there  was no 
s ignif icant  execut ive dysfunct ion on a  composi te  
evaluat ion of  updat ing and inhibi t ion tasks .  Ruis  e t  a l  in  
20095 6  observed that  there  is  no impairments  on a  set  of  
un-specif ied execut ive tasks  for  a  sample of  183 old aged 
adul ts  with recent ly  diagnosed type 2 Diabetes  Mell i tus .  
The resul ts  were in  agreement  with  pr ior  l i terature  
reviews,  which descr ibe an inconsis tent  re la t ionships  of  
affects  of  type 2  Diabetes  Mell i tus  on execut ive funct ion.  
Paul  e t  a l  in  20095 7  evaluated elder ly  diabet ics  with  
or  without  per ipheral  neuropathy,  by asking them to 
perform a ser ia l  mental  subtract ion task,  and carrying of  a  
t ray with water-f i l led cups during walking.  I t  was found to  
s ignif icant ly  s low the gai t  speed in  15 of  them with 
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diabetes  mel l i tus  and no cl inical  s igns of  per ipheral  
neuropathy by approximately 27%. These tasks  a lso 
decreased s tep  length in  these d iabetes  mell i tus  with  no 
per ipheral  neuropathy by up to  20% and increased their  
double-support  t ime by approximately 17%. These changes 
did not  show any s ta t is t ical ly  s ignif icant  dif ference when 
compared to  the ones el ici ted  in  with  diabet ic  mell i tus  
pat ients  with  per ipheral  neuropathy.  This  seems to  re-
emphasize a  gross  and vi ta l  l imitat ion in  the execut ive  
funct ion abi l i ty  that  is  needed to  divide the  at tent ion 
between the var ious  tasks ,  which is  a  central  l imitat ion,  
ra ther  than a  l imitat ion occurr ing due to  somato-sensory 
neural  pathway affect ion in the form of  diabet ic  
neuropathy,  which is  a  per ipheral  l imitat ion.  
POSSIBLE MECHANISMS OF IMPAIRED 
COGNITION: 
Cognit ive dysfunct ion in  diabetes  mell i tus  range from 
subcl inical  to  subt le  to  severe def ici t  l ike dementia6 1 .  
Cogni t ive funct ion is  affected  in  diabetes  mel l i tus  by  
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 Hypoglycemia  
 Hyperglycemia 
 Hyper insul inemia 
Executive Dysfunction and Hypoglycemia:  
The brain being an high energy consuming organ,  i t  
u t i l izes  upto 25% of  total  body glucose for  adequate  
funct ioning6 2 .  The normal  blood glucose level  is  a  range 
between 3.9  to  7 .1 mM (1 mM ~18 mg/dl) .  Blood glucose 
level  below which brain funct ion deter iorates  is  3  
mmol/ l (54 mg%).  In Diabetes  Mell i tus  pat ients ,  not  only 
severe  hypoglycemia (<2 mmol~  36mg%) but  a lso 
recurrent  mi ld (3 .2  -  3 .6  mmol~  58 -  64mg%) or  moderate  
(2 .3  -3 .2  mmol~42 -58mg%) hypoglycemia have 
deleter ious affects  on brain6 2 - 6 5 .  Lat ter  two (recurrent  mild 
and moderate  )  are  s ignif icant ly  more common than severe  
hypoglycemia6 5 .  Hypoglycemia occurs  more commonly 
with  intensive insul in  therapy 6 5 .  
Acute  hypoglycemia affects  a t tent ion,  mental  
f lexibi l i ty  and associat ive learning6 6 , 6 7 .  Recurrent  mild and 
moderate  hypoglycemia causes  greater  level  of  inte l lectual  
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decl ine especial ly  with performance IQ,  impaired mental  
abi l i t ies  and shor t  term memory def ici ts6 6 .  Many 
experimental  as  wel l  as  c l inical  s tudies  have shown that  
severe  hypoglycemia for  a  durat ion of  least  ten minutes  
resul t  in  act ivat ion of  microgl ial  cel ls .  The oxidat ive  
s t ress  that  occurs  resul ts  in  re lease of  many neuro- toxic  
substances ,  l ike  superoxide(SO3),  ni t r ic  oxide(NO),  and 
metal lo-proteinases .  These neurotoxins  cause wide spread 
neuronal  cel l  death  in  the cerebral  cortex  and 
hippocampus6 8 - 7 0 .  Scat tered neuronal  death in  the  I I  and II I  
layers  of  cerebral  cor tex as  wel l  as  in  hippocampal  CA1 
dendri t ic  region is  caused by recurrent  hypoglycemia of  
moderate in tensi ty7 1 , 7 2 .  Repet i t ive  mild and moderate  
hypoglycemia causes  cogni t ive impairment  adul ts  probably 
as  a  resul t  of  deter iorat ion due to  synapt ic  injury.  This  
type of  synapt ic  insul t  resul ts  in  i ts  inabi l i ty  to  induce or  
maintain  a  pers is tent  inhibi t ion of  LTP(long term 
potent ia t ion)  as  wel l  as  faci l i ta t ion of  LTD(long term 
depression)  a t  hippocampal  CA1 (which is  important  for  
memory)  without  an apparent  neuronal  somatic  injur ies .  
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Hence i t  causes  act ivi ty-dependent  synapse weakening 
leading to  cogni t ive impairments7 4 , 7 5 .  
Executive Dysfunction With Hyperglycemia:  
The et iology of  execut ive impairment  due to  
hyperglycemia is  mult i factor ia l .  At  experimental  level ,  
hyperglycemia induced detr imental  effects  on learning ,  
memory as  wel l  as  execut ive dysfunct ion were observed in  
GK rat 7 5 ,  Zucker  rat  (genet ic  models  of  Type2Diabetes  
Mell i tus) .  These rats  were evaluated  with  
1 .  Morris  water  maze spat ial  tes t  
2 .  inhibi tory or  act ive avoidance tasks  
3 .  object  discr iminat ion task tes ts ,   
They al l  showed s ignif icant  impairment  in  
hippocampus and i ts  interconnected s t ructures 7 5 , 7 6 .  
Chronical ly  e levated blood sugar  levels  as  wel l  as  Type2 
diabetes  mell i tus  causes blood brain  barr ier  disrupt ion.  
Hyperglyemia causes  modif ied insul in  t ransporter  as  wel l  
as  down regulat ion of  insul in  receptors  .These 
Transporters  and receptors  are  present  in  discrete  neuronal  
populat ions in  the CNS.  Further  hyperglycemia causes  a  
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decrease in  factors  l ike  insul in  l ike  growth factor  1  and i ts  
brain  der ived neurotropic  factor7 8 - 8 0 .  
 Cl inical ly ,  adul t  Diabetes  Mell i tus  pat ients  score low 
in IQ evaluat ion tes ts  and have less  scores  in  forward digi t  
span,  backward span tes t .  They also show a decl ine in  
score levels  in  memory,  comprehension tes ts .  Visual  
reasoning,  pat tern analysis ,  quant i ta t ion,  are  also equal ly  
affected.  As far  as  associate  learning,  psychomotor  
eff ic iency,  problem solving abi l i ty ,  informat ion processing 
speed are  concerned,  they are  also equal ly affected .  Many 
s tudies  reported that  execut ive dysfunct ion is  highly 
correlated with  the level  of  chronic  hyperglycemia .  
Improvement  in  performance of  execut ive funct ion tes t ing 
occurs  with  improvement  in  glycemic control 8 1 - 8 5 .   
The neurophysiological  s tudies  observed 
abnormali t ies  in  P300 component  of  ERPs.  Event  re la ted 
potent ia ls  are  physiological  analogue of  cogni t ive tes t ing .  
The I-I I I  and I-V inter-peak la tencies  of  the audi tory  
brainstem response are  prolonged in  Type2 diabetes  
mel l i tus  pat ients .  This  prolonged inter-peak is  regardless  
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level  metabol ic  derangement  and diabetes  mell i tus  
durat ion 8 6 , 8 7 .   
The more typical  pat tern of  cogni t ive def ic i ts  in  
diabet ics  is  suggest ive of  f rontal  sub-cort ical  dysfunct ion 
from a micro-vascular  insul t .  Structural  brain imaging 
s tudies  in  type 2 diabet ics  between ages  60 to  65 years  
revealed an increase in  both cerebral  a t rophy and lacunar  
infarcts .  This  pat tern  of  microvascular  d isease of  the brain 
is  character is t ical ly  associated with cardiovascular  r isk  
factors .  In  par t icular  this  f rontal  subcort ical  syndrome 
manifests  with  s ignif icant  execut ive impairment ,  motor  
s lowing and mood symptoms,  with minimal  memory loss .  
These defici ts  impact  on the individuals’  abi l i ty  to  plan,  
organize,  problem solve,  reason and also l imits  thei r  
ins ight8 8 , 8 9 .  
Longi tudinal  and populat ion based s tudies  have 
implicated type 2 diabetes  mell i tus  as  a  r isk factor  for  age 
re la ted cogni t ive decl ine and dementia .  Cogni t ive 
impairments  have been evidenced in  mult ip le  cross-
sect ion,  longi tudinal ,  and prospect ive s tudies .  
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Vijayakumar et  a l  in  20109 0  suggested hyperglycemia 
al ters  funct ion through a  var ie ty  of  mechanisms including 
polyol  pathway act ivat ion,  increased formation of  
advanced glycat ion end products ,  d iacylglycerol  act ivat ion 
of  protein  kinaseC and increased glucose shunt ing in  the  
hexosamine pathway leading to  changes in  cogni t ive 
funct ion that  have been detected  in  pat ients  with  diabetes .  
At  the neuroimaging level ,  cont inuous ar ter ia l  spin 
label ing MRI has  shown s ignif icant  decreased cerebral  
blood f low resul t ing in  cor t ical  and sub-cort ical  a t rophy9 1 .  
Suggested causes  of  hyperglycemia induced Execut ive 
dysfunct ion are   
1 .  Diabet ic  vasculopathy,   
2 .  hyper- l ipidemia,   
3 .  hypertension,   
4 .  insul in  res is tance  
5 .  hyper- insul inemia 
6.  dysregulat ion of  l imbic-hypothalamic-adrenal  
pi tui tary  axis  (LHPA) 
7.  chronic  hyperglycemia induced direct  
cytotoxici ty  on neuronal  cel ls .  
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8.  advanced glycat ion products  
9 .  Inf lammatory mediators  l ike  cytokines  
10.  oxidat ive s t ress  
11.  diabetes  re la ted depression 
      Adults  Type2diabetes  mel l i tus  pat iens  have higher  
serum levels  of  NSE (Neuron specif ic  Enolase –  a  specif ic  
marker  of  neuronal  cel l  damage) .Higher  NSE levels  
correlated well  with execut ive dysfunct ion This  correlat ion 
between NSE level  and Execut ive funct ion is  regardless  of  
the level  of  glycemic control ,  hence,  implicat ing direct  
Neuronal  injury of  chronic-hyperglcemia 9 2 .  
Pathophysiological  Mechanisms of  Executive 
Dysfunction in Diabetes:  
Neuroanatomical  Changes:  
Manschot  SM –etal 9 3  in  their  s tudy involving 164 
older  adul ts ,  of  which113who had type 2 Diabetes  mel l i tus ,  
exhibi ted up-to  23% cort ical  a t rophy,  12% sub-cort ical  
a t rophy more than non-diabet ics .  Further  Diabet ics  had  
s ignif icant ly  greater  number  deep white  matter  les ions and 
more numberof  infarcts  than those without  type 2 Diabetes  
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mell i tus .  These invest igators  a lso noted a  small  to  
moderate ,  but  s ta t is t ical ly  s ignif icant  def ic i ts  in  cogni t ive 
funct ions l ike 1 .a t tent ion 2.processing speed 3.  memory in  
diabet ic  mell i tus  pat ients .  
Glycemic Control  and Executive Dyfunction:  
 Many animal  models  have shown that  increased blood 
glucose levels  may promote the  format ion of  –   
1 .  Advanced glycat ion products ,  
2 .  React ive oxygen species  –  S03 
3.  Act ivat ion of  polyol  /  protein  kinase C pathway 
4.   Increased glucose by-passing in  to  the hexos-
amine pathways,   
5 .  Al tered  Neuro-transmit ter  funct ions   
Munshi  M, eta l  in  20069 4  demonstrated that  glycated  
hemoglobin levels  and measures  of  working memory have 
s ignif icant  inverse  re la t ionships .  Similar  s ignif icant  
inverse  re la t ionships  exis t  between HbA1c and measures  of  
visuo-spat ia l  funct ion.  
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 Ha T.  Nguyen etal 3  in  2010 examined the associat ion  
between glycemic control  and the execut ive funct ioning 
domain of  cogni t ion in  ninety-f ive rural  older  adul ts  wi th  
diabetes  found that  suggest  that  poor  glycemic control  is  
associated with  impairments  in  performance on composi te  
measures  of  execut ive funct ion,  and that  this  re la t ion may 
be explained by modif iable  r isk  factors  for  glycemic 
control  such as  use of  diabetes  medicat ion and diabetes  
knowledge.  
INSULIN RESISTANCE AND EXECUTIVE 
DYSFUNCTION: 
 I t  i s  now known that  insul in  plays  important  neuro-
t rophic  roles  by interact ing with receptors  a l l  over  the 
brain ,  which also includes regions that  are  thought  to  be 
cr i t ical  for  execut ive funct ional  abi l i t ies9 5 .  Newer 
evidence are  point ing that  insul in  res is tance probably  
promotes  the development  of  the β -amyloid plaques  or  
inhibi t  their  degradat ion.  β -Amyloid plaques character is t ic  
of  Alzheimer  disease9 6 .  
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VASCULAR DISEASE AND EXECUTIVE 
DYSFUNCTION: 
 Newer s tudies  are  suggest ing that  vascular  
dysfunct ion could be contr ibut ing to  execut ive dis turbance.  
Neuro-pathic  and angio-pathic  a l terat ions  have been noted 
in  the cranial  nerves and per ipheral  nervous system 
including spinal  cord of  the diabet ic  pat ients .  Vasodi lat ion  
is  disrupted by the harmful  combinat ion of  inadequate  
cerebral  blood f low and hyper-act ivat ion of  the  
thromboxane A2 (TX-A2) receptor .  The resul tant  ischemia  
is  propably exacerbated due to  associated hyperglycemia in  
diabet ics ,  thereby providing a  favorable  environment  
mil ieu for  damaging agents  l ike  lactate  and /  or  glutamate,  
whose accumulat ion can cause the neural  injury 9 6 , 9 7 .  
The Rot terdam study 1 0  (cross-sect ional  s tudy using 
dementia  as  a  var iable)  showed a  s ignif icant  associat ion 
between diabetes  mel l i tus  and dementia ,  wi th  the s t rongest  
associat ion for  vascular  pat tern dementia.  Important ly  this  
was found to  be independent  of  educat ion,  body mass  
index,  a therosclerosis ,  smoking,  blood pressure  or  the use 
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of  ant ihypertensive agents .  I t  was a lso not  explained by 
cerebral  infarcts .   
The Hisayama Study 1 0  (seven year  fol low-up of  828 
diabet ic  residents  aged 65 years  and over  without  basel ine 
dementia)  demonstrated an increased r isk of  vascular  
dement ia .  
In  a  cross-sect ional  populat ion based s tudy of  home 
bound individuals  diabet ics  had a  worse MMSE score:  
24/30 vs  25.7/30.  Only 50% of  diabet ic  individuals  
successful ly  reproduced the pentagon i l lus t ra t ion whereas  
68% of  non-diabet ics  were successful .  However  more 
sensi t ive tes ts  of  execut ive funct ion such as  the Trai l  B 
demonstrated s ignif icant ly  worse scores  for  diabet ics 5 0 .  In  
a  large cohort  (10963 pat ients  assessed at  two separate  
occasions s ix  years  apar t )  those with diabetes  a t  basel ine 
had a  greater  decl ine in  scores  on two separate  execut ive 
measures:  digi t  symbol  subset  and f i rs t - le t ter  word 
f luency.  This  pers is ted af ter  control l ing for  demographic  
and vascular  r isk  factors ,  and was also demonstrated when 
rest r ic ted to  a  younger  age group of  47-57 years .  In  a  
l i terature  review by Stewart  e t  a l .  a  s t rong associat ion 
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between poor  verbal  f luency scores  and type 2 diabetes  
mel l i tus  was demonstrated9 8 .  
Though i t  i s  di f f icul t  to  e lucidate  the impact  of  
diabetes  mell i tus  on Execut ive funct ion,  i t  seems possible  
that  disease-mediated changes in  execut ive funct ion do 
adversely affect  the  dai ly  funct ional  abi l i t ies  in  pat ients  
with  type 2 Diabetes  Mel l i tus .   
The purpose of  this  s tudy is  to  assess  execut ive funct ion in  
pat ients  with  type 2 Diabetes  mel l i tus  in  comparison to  
normal  subjects .  
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AIM 
To assess  execut ive funct ioning in  type 2  diabet ic  pat ients  
compared to  normal  subjects  
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NULL HYPOTHESIS 
There is  no difference between the s tudy and control  
groups,  in  tes ts  of  execut ive funct ion.  
Ethics  Committee :  
The s tudy was approved by the Inst i tut ional  Ethical  
Commit tee ,  Madras  Medical  Col lege vide le t ter  No 
20092013.  
All  subjects  (both pat ients  and control  group)  gave 
informed consent  for  par t icipat ion in  wri t ten  form.  
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MATERIALS AND METHODS 
The s tudy is  a  cross  sect ional  case control  s tudy,  
conducted at  the  Raj iv  Gandhi  Government  General  
Hospi ta l (RGGGH),  Chennai .  50 pat ients  a t tending 
outpat ient  depar tment  of  Diabetology,  fulf i l l ing the 
inclusion cr i ter ia  were randomly chosen and included in  
the s tudy.  Fif ty  consent ing age,  sex,  educat ion matched 
normal  people  who were relat ives  of  pat ients  a t tending 
RGGGH OPD were taken as  controls .  Both the s tudy 
populat ion and controls  were adminis tered the semi  
s t ructured proforma.  Then GHQ and HAM D was  
administered to  screen for  psychiatr ic  symptoms.  Those  
who scored posi t ively were excluded from the s tudy.  
MMSE was adminis tered as  a  screening tool  for  cogni t ion.  
All  d iabetes  mel l i tus  pat ients  were tes ted for  their  blood 
glucose level  before adminis ter ing the evaluat ion tes ts .  
This  was done to  avoid hypoglycemia /  severe  
hyperglycemia affect ing the execut ive funct ion assessment .    
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SUBJECT SELECTION:  
50 pat ients  with  type II  DM at tending Diabetalogy OPD in  
RGGGH  
50 normal  subjects  (a t tenders  of  pat ients  a t tending the 
OPD) 
 
INCLUSION CRITERIA:  
GROUP A: 
1.  Age 40 – 50 years  
2 .  Type II  DM diagnosed as  per  American Diabetes  
Associat ion Cri ter ia  
3 .  Giving informed consentCooperat ive for  Cogni t ive 
Assessment  
GROUP B: 
1.  Age & gender  matched NonDiabetes  
2 .  Giving informed consent  Cooperat ive for  Cogni t ive 
Assessment  
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EXCLUSION CRITERIA:   
GROUP A: 
1.  Co-Morbid Medical  i l lness  
2 .  Co-Morbid Psychiatr ic  i l lness  
3 .  Co-Morbid Neurological  i l lness  
4 .  H/o of  substance dependence 
5.  Intel lectual  Disabi l i t ies  
6 .  Long term benzodiazepine use 
 
GROUP B: 
1.  Co-Morbid Medical  i l lness  
2 .  Co-Morbid Psychiatr ic  i l lness  
3 .  Co-Morbid Neurological  i l lness  
4 .  H/o of  substance dependence 
5.  Intel lectual  Disabi l i t ies  
6 .  Long term benzodiazepine use 
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ASSESSMENTS OF PARAMETERS: 
1.  Proforma for  socio demographic  data  of  s tudy cases  
and control  group 
2.  Proforma for  Diabetes  Status  
3 .  Mini  Mental  State  Examinat ion (MMSE) 
4.  Test  for  Execut ive Funct ion:  
a .  Digit  Span Test  
i .  Forward Digi t  span 
i i .  Reverse digi t  span 
b.  Verbal  f luency 
i .  Letter  f luency 
i i .  Category Fluency 
c .  Trai l  making tes t  
i .  TMTA  
i i .  TMTB 
d.  Stroop Test  
e .  Wisconsin Card Sort ing Test  
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1.  DIGIT SPAN TEST: 
The Digi t  Span Test  is  a  br ief  tes t  to  evaluate  the 
person 's  cogni t ive funct ion.  I t  i s  commonly used in  by the 
physician to  rapidly evaluate  the normali ty  of  pat ient ' s  
cogni t ive  funct ion and mental  abi l i t ies .  
Digi t  Span Test  was or iginal ly  a  component  of  
Wechsler ' s  Inte l l igence Scale .  Wechsler ' s  In tel l igence 
Scale  i s  used evaluate  and measure the pat ient’s  IQ 
( intel l igence quot ient)  
In  digi t  span tes t  the  subject  is  inst ructed to  repeat  a  
ser ies  of  numbers  in  the same order  as  said to  them. The 
evaluator  then ut ters  a  ser ies  of  three numerical ,  such as  
"4,1,  8 ."  Numbers  are  said in  a  c lear  mono-tone voice ,  
each one a  second apar t  form the next  one.  The subject  
then has  to  repeat  back those numerical  in  the same order  
as  said,  back to  the evaluator .  The next  level  is  to  give a  
ser ies  of  4  numbers ,  such as ,  "5,  8 ,  3 ,  6 ."  Even this  t ime,  
the subject  has  repeat  those numbers  back to  the evaluator .  
This  cont inues in  the same sequent ial  ser ies  wi th  
progress ively increasing the ser ies  of  numerical  to  5  and 
the subject  has  to  repeat  the  very same numerical  back to  
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the evaluator .  The evaluator  cont inues to  keep on 
increasing the ser ies  of  numerical  in  order  of  one every 
t ime and then asking the subject  to  repeat  them back to  the  
evaluator  as  a long as  the answers  are  correct  and s tops  
when a  response is  incorrect .  Similar ly  in  the  backward 
digi t  span task the par t ic ipant  needs to  reverse the order  of  
the numbers .  Of  the two the Forward Digi t  span tes t  i s  
re lat ively eas ier  when compared to  the backward digi t  span 
tes t .   
2.  VERBAL FLUENCY TEST: 
The verbal  f luency tes t  is  a  short  screening tes t  that  
evaluates  cogni t ive funct ion.  The Verbal  Fluency bat tery 
includes  tes ts  for  Let ter  and Category f luency.  In  Verbal  
f luency tes t  the subject  is  evaluated for  maximum number  
of  word product ion,  within a  set  t ime frame,  and within a  
specif ic  constraint ,  e .g . ,  words s tar t ing with the alphabet  
“S” --  Let ter  Fluency Test ,  or  name of  birds  /  animals  - -  
Category Fluency tes t .  This  is  an execut ive funct ion task  
where s t rategies  such as  c luster ing can be implemented in  
order  to  faci l i ta te  word product ion.  In  the Let ter  Fluency 
tes t ,  the  subject  is  give three separate  one-minute  t r ia ls  for  
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the let ters  F,  A,  and S.  The Category Fluency tes t  is  a  one-
minute  t r ia l  for  a  s ingle  category l ike  birds  which can f ly ,  
four  legged land animals  e tc .  For  Subjects  not  prof ic ient  
Engl ish ,  in  case of  the Let ter  Fluency Test ,  3  le t ter  of  their  
Vernacular  language is  given. Example – (அ ,  க ,  த)  
3.  WISCONSIN CARD SORTING TEST  
(MILNAR 1963):  
Wisconsin card sor t ing tes t  developed by Milnar  in  
1963 is  used to  tes t  the  set -shif t ing abi l i ty .  I t  was 
or iginal ly  developed to  assess  abstract  reasoning abi l i ty  
and the abi l i ty  to  shif t  cogni t ive s t ra tegies  in  response to  
changing environmental  cont ingencies .  I t  consis ts  of  s ixty 
four  tes ts  cards  and 4 s t imulus  cards .  Each card is  a  square  
of  dimensions 8cms by 8cms.  The s t imul i  vary in  3 
at t r ibutes:  color  ( red ,  green,  yel low,  blue) ,  form ( t r iangle ,  
s tar ,  cross ,  c i rcle)  and number(1 ,2,3 ,4) .  Of these four  
s t imulus  card the f i rs t  card consis t  of  one red t r iangle ,  the  
second card consis t  of  2  green s tars ,  the  third  card consis t  
of  3  yel low crosses  and the fourth  card consis t  of  4  blue 
circles .  
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The four  s t imulus  cards  are  placed in  f ront  of  the  
subject ,  wi th  one red t r iangle  placed on the lef t  had s ide of  
the  subject .  Next  to  i t  i s  the card with two green s tars ,  
fol lowed by the card with 3  yel low crosses  and on the 
extreme r ight  the  card with  4  blue circles .  The deck of  64 
cards  is  arranged according to  the sequence of  presentat ion 
given in  the tes t  manual  and placed to  the lef t  s ide of  the  
subject .  The subject  is  asked to  s tudy the cards  and match 
each successive card f rom the pack to  one of  the four  
s t imulus card.  The subject  is  told  only whether  each  
response is  r ight  or  wrong and never  about  the  correct  
sor t ing pr incipal .  Each t ime the subject  places  a  card 
according to  the sor t ing pr incipal  i t  i s  scored s tar t ing from 
1 and cont inued ser ia l ly  for  consecut ive correct  responses .  
After  10 consecut ive correct  responses ,  the  examiner  
changes the concept  without  the knowledge of  the subject .  
The f i rs t  matching pr incipal  is  by color  then form and 
f inal ly  number .  This  sequence is  repeated.  
Scoring in Wisconsin card sorting test:  
The scoring is  done for  the   
1 .  Number of  t r ials  adminis tered,   
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2.  Total  number  of  correct  responses ,   
3 .  Total  number  of  errors ,   
4 .  Percent  errors ,   
5 .  Perseverat ive responses ,   
6 .  Percent  perseverat ive responses ,   
7 .  Perseverat ive errors ,   
8 .  Percent  perseverat ive errors ,   
9 .  Non-perseverat ive errors ,   
10.  Percent  non perseverat ive errors ,  conceptual  level  
responses ,  Percent  conceptual  responses ,  Number  of  
categor ies  completed.  
1 .  Responses  that  match sor t ing pr inciple  are  scored as  
correct  while  incorrect  responses  are  scored as  
errors .  
2 .  Response is  addi t ional ly  scored as  ambiguous or  
unambiguous  
3 .  When a  c l ient  pers is t  in  responding to  a  s t imulus  
character is t ic  that  is  incorrect ,  the  response is  said  to  
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be perseverated  to  pr inciple  and scored as  
Perseverat ive  
4 .  Responses  not  matching to  perseverated to  pr inciple  
are scored Non perseverat ive .  
5 .  The perseverated  to  pr inciple  is  es tabl ished at  the 
beginning of  the tes t  the  f i rs t  t ime the cl ient  makes 
an  unambiguous error  
6 .  The f i rs t  unambiguous response to  match the new 
perseverated  to  pr inciple  is  an unambiguous 
perseverat ive  error  
7 .  Number of  categories  completed  i s  s imply the number 
of  categories  –  10 consecut ive correct  matches  the 
cl ient  completed 
8.  Trials  to  complete  f irs t  category i s  to ta l  number  of  
t r ia ls  to  successful ly  complete  f i rs t  category  
9.  Percent  perseverat ive  errors  :  densi ty  of  
perseverat ive errors  
 
 53
10.  Failure to  maintain set  :  error  fol lowing f ive or  more 
consecut ive correct  response before  category 
complet ion  
11.  Percent  Conceptual  level  response  :  Reflects  insight  
into  correct  sor t ing pr inciple  
12.  Learning to  learn :  Average change in  conceptual  
eff iciency .  
4.  STROOP TEST (ALEXANDER, STUSS,1989):  
This  tes t  measures  the response inhibi t ion abi l i ty .  
Three cards  which has  20 rows and 5 columns of  e i ther  
color  names or  symbol  is  presented.  Firs t  card has  color  
names pr inted in  black color ,  second card has  x  symbol  
pr inted in  different  colors .  And las t  card has  color  names 
blue,  green ,  and red pr inted in  different  colors  (  e .g .  red  
pr inted  in  green color) .   
Firs t  card is  presented to  the subject  and asked to  
read the color  words a long the column.  Then,  second card 
is  given and the number  of  X symbols  read is  noted.  Third 
card given and the subject  has  to  read the color  in  which 
the color  names are  pr inted and not  the  color  names.  The 
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t ime taken to  read each card ( t1 ,  t2 ,  t3)  and the number  of  
errors  made is  noted.  The Stroop effect  is  calculated as  :  
t3-( t1+t2 /  2) .  
5.  TRAIL MAKING :   
Trai l  Making Test  has  two par ts  A and B.  Each par t  
consis ts  of  25circles  drawn on a  plain white  paper .  In  t ra i l  
making Test-A,  the ci rcles  are  numbered from one to  
twenty f ive.  The evaluator  asks the subject  to  draw l ines  
connect ing the numbers  in  ascending order .  For  t ra i l  
making tes t  -  B,  the c i rc les  are  marked with numbers  (1  – 
13) ,  while  remaining circles  are  labeled wi th  le t ters  (A – 
L);  The evaluator  then asks  the subject  to  connect  the  
c i rc les  in  an order  of  ascending,  but  the extra  task is  to  
a l ternate  between le t ters  and numbers( i .e . ,  1-A-2-B-3-C,  
e tc . ) .  The subject  is  to  connect  the circles  as  fast  as  
possible ,  and without  l i f t ing the marker  off  the paper .  
Time taken for  complet ion the t ra i l  marking is  penned in  
separately  for  Trai l  marking tes t  A,B .  I f  an error  is  done 
during marking of  t ra i l ,  i t  i s  pointed as  correct ion is  
a l lowed.  But  Errors  do affect  the subject’s  score in  a  way,  
that  the correct ion of  errors  is  included in  the complet ion 
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t ime for  the task  only.  Maximum t ime give for  complet ion  
of  task is  5  minutes  and af ter  which the tes t  is  cal led off ,  
as  i t  i s  unnecessary to  cont inue fur ther .  
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OPERATIONAL DESIGN: 
This was a hospital based study, conducted at Institute of Mental 
Health, Madras Medical College, Chennai in a cross sectional 
comparative design, for a period of three months. Approval from the 
Institutional Ethical Committee, Madras Medical College was obtained. 
The sample was chosen from Diabetology outpatient department of 
RGGGH, Chennai-3 .  Patients diagnosed as Type 2 diabetes Mellitus 
were chosen as cases and attendenders accompanying the patients 
attending RGGGH, Chennai-3 as controls. All the cases and controls 
were screened depending on the inclusion and exclusion criteria, were 
included in the study. 
The study subjects were explained about the nature of the study 
and consent was obtained. Socio demographic details as per proforma 
collected from cases and controls. Complete physical examination 
including detailed Neurological evaluation was done. Subsequently, all 
subjects were given the scales and cognitive assessments as mentioned. 
Tests were administered in a quiet room in a fixed pre-set order according 
to standard administration instructions.  The time taken was about 1hr to 
1hr and 30 minutes. Assessments were carried out in 1-2 sessions, each 
session not extending beyond 1 hour. 
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DATA ANALYSIS 
STATISTICAL ANALYSIS PLAN: 
Comparison of  socio demographic  data  of  s tudy and 
control  groups:  
Chi  square  tes t  
Comparison of  execut ive funct ion of  s tudy and control  
groups:  
Assessing normali ty  of  data  for  cases  and controls  
a .  Shapiro-Wilk  tes t .  
b .  Kolmogorov-Smirnov tes t .  
Comparison of  neuropsychological  scores  between 
cases(s tudy group)  and controls .  
1 .  When data  dis t r ibuted Normally  
i .  2 Tai led Students  T tes t  
2 .  For Non-Normative dis t r ibut ion of  data  
i .  Wilcoxon – Mann-Whitney U tes t  (non-parametr ic  
tes t ) .  
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RESULTS  
The s tudy is  a  case control  s tudy,  cases  def ined as  
Type2 Diabetes  mell i tus  and controls  as  heal thy unrelated  
subjects .  
A.  Socio-demographic  data  of  cases  and controls  
With respect  to  s tudy populat ion (cases) ,  26(52%) 
were between than 40 year  –  45 years  of  age,  and 24(48%) 
were between 45 years  –  50 years .  Sex dis t r ibut ion was,  
21(42%) males  and 29(58%) females .  And 37 (74%) had a  
secondary educat ion,  whi le  13 (26%) had a  degree.  
With respect  to  control  group) ,  28 (56%) were 
between than 40 year  –  45 years  of  age,  and 22(44%) were 
between 45 years  –  50 years .  Sex dis t r ibut ion among 
control  was 26 (52%) male and 24 (48%) female .  Control  
group dis t r ibut ion in  educat ion was 36 (72%) had a  
secondary educat ion,  whi le  14 (28%) had a  degree.  
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Table 1 : Socio-Demographic Data 
 Cases Control 
 Number Percent Number Percent 
Age  
40 – 45 
46 – 50 
26 
24 
52 
48 
28 
22 
56 
44 
Sex : male 21 42 24 48 
Female 29 58 26 52 
Education :secondary 37 74 36 72 
Degree 13 26 14 28 
Occupation:     
Unskilled 31 62 28 56 
Semiskilled 19 38 20 40
Skilled 0 0 2 4 
Marital status : married 50 100 50 100 
Domicile: rural 11 22 12 24
Urban 39 78 38 76 
SES: Low 6 12 5 10 
Middle 44 88 45 90 
Religion: Hinduism 
Christianity Islam 
40 
7 
3 
80 
14 
6 
37 
9 
4 
74 
18 
8 
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Table 2: Comparison of socio-demographic data 
Socio-demographic 
data Cases(n=50) Controls(n=50) 
 
χ2 
Age 
40 – 45 
46 – 50 
 
26 
24 
 
28 
22 
 
0.568 
Sex : 
Male 
Female 
 
21 
29 
 
24 
26 
 
0.546 
Education: 
Secondary 
Degree 
 
37 
13 
 
35 
14 
 
0.752 
Occupation : 
Unskilled 
Semiskilled 
Skilled 
 
31 
19 
0 
 
28 
20 
2 
 
0.305 
Marital status : 
Married 
Unmarried 
 
50 
0 
50 
0 
 
 
SES : 
Low 
Middle 
 
6 
44 
 
7 
43 
 
0.683 
Religion : 
Hinduism 
Christianity 
Islam 
 
40 
7 
3 
 
37 
9 
4 
 
0.625 
 
No s ignif icance seen in  chi  square tes t ing 
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Comparison of  socio-demographic  data  of  cases  and  
controls  shows no s ignif icant  d if ference.  Hence the two 
groups are  comparable  with respect  to  age,  sex  
dis t r ibut ion,  educat ion,  occupat ion,  socioeconomic s ta tus .  
C. ILLNESS CHARACTERISTICS OF DIABETES 
MELLITUS PATIENTS: 
The table  3  below shows the detai ls  regarding the 
i l lness  character is t ics  of  Diabetes  Mell i tus  pat ients .  
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Table :  3  I l lness  characterist ics  of   
Diabetes  Mell i tus  patients  
Disease 
Characteristics 
VARIABLES 
Age Of Onset   
In Yrs <30 30 – 35 36 – 40 41 – 45 46 – 50 
No. Of Patients 2 4 8 30 6 
Percentage 4% 8% 16% 60% 12% 
Duration Of 
Illness 
0 -12 
months 
12 – 24 
month 
24 – 36 
months 
3 – 5 
yrs 
>5 
yrs 
No. Of Patients 2 6 12 20 10 
Percentage 4% 12% 24% 40% 20% 
Type Of 
Trearment 
Diet / 
Exer 
D&E + 
OHA 
D&E + 
OHA + 
Insuin 
D&E +I 
 
 
No. Of Patients 0 40 10 0  
Percentage 0 80% 20% 0  
Presence Of 
Complications 
NEGATIVE 
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The mean age of  onset  of  diabetes  mell i tus  is  41.40 
years  and the mean durat ion of  i l lness  is  < 5 years .  There  
was no major  macro /  micro vascular  complicat ion.   
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AGE DISTRIBUTION 
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GENDER DISRIBUTION 
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70%
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EDUCATION 
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OCCUPATION 
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MARITAL STATUS 
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D. ASSESSMENT OF NORMAL DISTRIBUTION OF 
DATA: 
Shapiro-Wilk test is used to assess the normal distribution of data. 
Table 4 : Assessing normality of data for cases and controls 
Tests of Normality 
CASE_CONT 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic Df Sig Statistic Df Sig 
STROOP 
TEST 
CASE 0.61 50 0.15 0.950 50 0.114 
CONTROL 0.07 50 0.027 0.904 50 0.002 
 
 Shapiro-Wilk test, which is a standard test used for assessing the 
normal distribution of data. The above table 4 gives the normality testing 
for cases and controls for Stroop test. The results were significant (0.114) 
for cases but not significant for controls (0.002). This means the data falls 
under normal distribution curve for cases but not controls, as depicted 
pictorially in the histogram. 
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Similar ly  for  Wisconsin card sor t ing tes t  score  of  errors  
(WCST),  Shapiro-Wilk tes t  shows normal  dis t r ibut ion for  
cases  but  Non-normal  dis t r ibut ion for  controls ,  which also 
depicted in  the his togram.  
 
 
 
 
 
 
 
 
 
Test for normality 
CASE_CONT 
Kolmogorov-
Smirnov Shapiro-Wilk 
Statistic Df Sig Statistic Df Sig 
WCST 
ERRORS 
CASE 0.30 50 0.15 0.962 50 0.229
CONTROL 0.01 50 0.01 0.887 50 0.001
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Tests of Normality 
CASE_CONT 
Kolmogorov-Smirnov Shapiro-Wilk 
Statistic Df Sig Statistic Df Sig 
WCST 
PRE 
CASE 0.03 50 0.01 0.881 50 0.001 
CONTROL 0.01 50 0.01 0.810 50 0.001 
 
The next data for Perseverative Response Errors shows non-normal 
distribution for cases and controls. 
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E. COMPARISON OF NEUROPSYCHOLOGICAL 
SCORES BETWEEN CASES (STUDY GROUP) AND 
CONTROLS: 
A total  of  5  neuropsychological  tes ts  (Digi t  span (forward,  
backward) ,  Verbal  Fluency (Let ter  and Category Fluency) ,  
Trai l  making tes t  –  A&B, Stroop tes t ,  and Wisconsin card 
sor t ing tes t ,  were adminis tered  to  cases  and controls ,  
yie lding 17 scores .  Higher  the scores  bet ter  the 
performance,  lower  the scores ,  poorer  the performance for  
Digi t  Span and Verbal  Fluency.  For  t ra i l  making tes t  the 
t ime taken to  complete  is  scored in  seconds.  Higher  the  
score ,  poorer  the performance.  For  Stroop tes t ,  Stroop 
effect  is  calculated,  higher  the  score  poorer  the  
performance.  The s tandard scores  f rom Wisconsin card 
sor t ing tes t  manual  are  entered for  each parameter .  Higher  
the  score  bet ter  the  performance.   
The Wilcoxon – Mann-whitney U tes t  (non parametr ic  tes t )  
is  used for  comparison of  neuropsychological  tes t  scores  of  
cases  and controls .  
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DIGIT SPAN TEST 
Table  5:  Forward dig i t  span 
 
FORWARD DIGIT SPAN 
 
TESTS CAES (n=50
CONTROLS 
(n=50) MANN- 
WHITN 
EYU 
WILC
O 
XONW 
 
Z 
 
SIGNIFIC 
ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
FDS  6.439 
 
0.884 
 
6.64 1.064 1104.5 2654.5 1.174 
 
.240 
 
For  Forward  Digi t  span  tes t ,  cases  group 
reproduced less  Numbers  (mean -  6 .439,  SD -  0 .884)  
compared  to  cont ro ls  (mean -  6 .64 ,  SD -  1 .064) .  The  
Mann-whi tney  Uscore ,  Wilcoxon W and Z scores  
compar ing  two groups  are  1104.5(U) ,  2654.5  (W),  1 .174 
(Z)  respect ive ly .   And the  tes t  scores  a re  s ta t i s t ica l ly  
not  s igni f icant  a t  p  –  0 .24 .  
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Table  6:  Backward dig i t  span  
 
TEST
S
CASES 
(n=50) 
 
CONTROL  MANN- 
WHITN 
EYU 
WILCO 
XON 
W 
 
 
Z 
 
SIGNIFI
C ANT2 
TAILED  
 
MEAN 
 
SD 
 
MEAN SD 
BDS 
 
4.36 
 
0.525 
 
4.52 0.667 1070.0 2345.0 
 
1.241 
 
0.214 
 
For  Backward  Digi t  span  tes t ,  cases  group 
reproduced less  Numbers  (mean -  4 .36 ,  SD -  0 .525)  
compared  to  cont ro ls  (mean -  4 .52 ,  SD -  0 .667) .  The  
Mann-whi tney  Uscore ,  Wilcoxon W and Z scores  
compar ing  two groups  are  1070(U) ,  2345 (W),  1 .241 (Z)  
respect ive ly .   And the  tes t  scores  a re  s ta t i s t ica l ly  not  
s ignif icant  a t  p  –  0 .214.  
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VERBAL FLUENCY 
Table  7:  Letter  Fluency 
 
LETTER FLUENCY 
 
TESTS CASES (n=50) 
CONTROLS 
(n=50) MANN- 
WHITN 
EYU 
WILC
O 
XONW 
 
 
Z 
 
SIGNIFIC 
ANT2 
TAILED   MEAN 
 
SD 
 
MEAN SD 
LF 
 
41.58 
 
3.540 42.22 2.772 1099.5 2374.5 
 
1.038 0.303 
 
For  Let te r  F luency tes t ,  cases  group produced less  
words  (mean -  41 .58 ,  SD -  3 .540)  compared  to  cont ro ls  
(mean -  42 .22 ,  SD -  2 .772) .  The  Mann-whi tney  U score ,  
Wilcoxon W and Z scores  compar ing  two groups  are  
1099.5(U) ,  2374.5  (W),  1 .038 (Z)  respect ive ly .   And the  
tes t  scores  are  s ta t i s t ica l ly  not  s igni f icant  a t  p  –  0 .30 .  
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Table  8:  Category Fluency  
 
CATEGORY  FLUENCY 
 
TESTS CASES (n=50) 
CONTROLS 
(n=50) MANN 
WHITN 
EYU 
 
 
WILC 
OXON
W 
 
 
Z 
 
SIGN 
IFIC 
ANT2 
TAILED 
  
MEAN
 
SD 
 
MEAN SD 
CF 
 
13.16
 
1.166 13.46 1.092 1070.5 2345.5 
 
1.237 0.218 
 
For  Category  Fluency tes t ,  cases  group produced 
less  words   (mean -  13 .16 ,  SD -  1 .166)  compared  to  
cont ro ls  (mean -  13 .46 ,  SD -  1 .092) .  The  Mann-whi tney  
U score ,  Wilcoxon W and Z scores  compar ing  two 
groups  are  1070.5(U) ,  2345.5  (W),  1 .237 (Z)  
respect ive ly .   And the  tes t  scores  a re  s ta t i s t ica l ly  not  
s ignif icant  a t  p  –  0 .218 
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TRAIL MAKING TEST 
Table  9:  Trai l  making test  A 
 
TMTA 
 
TESTS CASES (n=50) 
CONTROLS 
(n=50) MANN 
WHITNEY
U 
WILC
O 
XONW 
 
 
Z 
 
SIG
N 
 
TMTA 
 
MEAN 
 
SD 
 
MEAN SD 
 
SECS 
 
32.13 
 
3.658 30.15 3.786 899.5 2174 
 
-2.416 0.015
 
Tra i l  making tes t  A tes ts  the  speed of  a  subjec t .  In  
th i s , cases  took  longer  t ime  to  comple te  the  t a sk  (mean  
32 .13 ,  SD 3 .658 )  when  comp ared  t o  t he  con t ro l  g roup 
(mean  30 .15 ,  SD 3 .786) .  Oncompar ing  the  per formance  
of  two groups ,  there  was  s ignif icant  d i f ference  wi th  p  <  
0 .015 ;  the  Mann-whi tney  U score  i s  899.5 ,  Wilcoxon W 
i s  2 1 7 4 . 0 0 0  a n d  Z  s c o r e  i s  - 2 . 4 1 6 .  
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Table  10:  Trai l  making test  B  
 
TMTB 
 
TESTS CASES (n=50) 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
O 
XON
W 
 
Z 
 
SIGNIFI
C ANT2 
TAILED 
 
TMTB 
 
MEAN 
 
SD 
 
MEAN SD 
 
SECS 
 
79.679 
 
14.808 
 
71.18 10.03 803 2078 -3.082 
 
0.002 
 
Tra i l  making tes t  B tes ts  the  se t -sh i f t ing  abi l i ty  of  a  
subjec t .  In  th is ,  cases  took longer  t ime to  comple te  the  
task  (mean 79 .679,  SD 14.808)  when compared  to  the  
cont ro l  group (mean 71 .18 ,  SD 10.03) .  On compar ing  
the  per formance  of  two groups ,  there  was  s igni f icant  
d i f ference  wi th  p  <  0 .002 ;  the  Mann-whi tney  U score  i s  
98 .000 ,  Wilcoxon W is  563.000 and Z score  i s  -3 .2078. 
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STROOP TEST 
Table  11:  s troop test  
 
                   STROOP 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
N EYU 
WILC
O 
XON
W 
Z  SIGNIFI
C ANT2 
TAILED STROOP 
 
MEAN 
 
SD 
 
MEAN SD 
SECS 
 
42.78 
 
7.197 
 
40.12 8.263 972.5 2251.5 -1.855 
 
0.059 
 
S t roop tes t  i s  used  to  tes t  the  response inhib i t ion  
of  execut ive  funct ioning .  I t  scores  the  t ime taken to  
comple te  each card  and the  number  of  e r rors  made in  
each .  The  St roop ef fec t  ca lcula ted  us ing  the  t ime fac tor ,  
shows cases  (mean 42 .78 ,  SD 7 .197) took more  t ime to  
comple te  the  task  compared to  the  cont ro l  group (mean  
40 .12 ,  SD 8 .263) .  Though the  er rors  were  not  used  in  
computa t ion  of  S t roop ef fec t ,  cases  made more  er rors  
compared  to  the  cont ro ls  in  th i rd  card .  The  scores  in  the  
Mann-whi tney  U is  972.5 ,  Wilcoxon W is  2251.5   and  Z 
score  i s  -1 .855 ;  the  d i f ference  in  the i r  per formance  was  
not  s ta t i s t ica l ly  s ignif icant  p<0.059.  
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WISCONSIN CARD SORTING TEST:  
Wiscons in  card  sor t ing  tes t  (WCST)  i s  the  gold  s tandard  
tes t  for  execut ive  funct ion  tes t ing .  The  raw scores  for  
each  parameter  were  noted  and the i r  cor responding 
s tandard  scores  entered  f rom tes t  manual .  The  overa l l  
per formance  was  margina l ly  be t te r  in  cont ro l  group 
compared  to  cases  who made more  number  of  e r rors  
( to ta l  and  persevera t ive)  and persevera t ive  responses .  
So  the  s tandardized  scores  were  margina l ly  low in  cases  
compared to  cont ro ls .  
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Table  13:  Wisconsin  card sort ing test  
 
 
W ERRORS 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
 
Z 
 
SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
ERROR 
 
118.28 
 
9.272 
 
119.00 9.64 1222 2497.0 0.193 
 
0.849 
 
 
WISCONSIN PERCENTAGE OF ERRORS 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
 
Z 
 
SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
ERROR% 
 
111.58 
 
10.862 
 
112.88 11.527 1177 2452.0 0.503 
 
0.617 
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WISCONSIN PRESEVATIVE RESPONSE 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
 
Z 
 
SIGNIFI
CANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
PE 
 
128.68 
 
16.739 
 
130.22 15.58 1184 2459.0 0.455 
 
0.652 
 
 
 
 
WISCONSIN PRESEVATIVE RESPONSE PERCENTAGE 
 
TESTS 
CASE
S 
CONTROL
S (n=50) 
 
MANN
WHIT
NEYU 
 
WILC
OXON
W 
 
Z 
 
SIGNIFI
CANT2 
TAILED  
 
MEAN 
 
SD 
 
MEAN
 
SD 
PR% 
 
118.22 
 
21.539 
 
121.10 
 
20.76 
 
1139 
 
2414.0 
 
0.765 
 
0.447 
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WISCONSIN PRESEVATIVE  ERRORS 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
Z  SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
PE 
 
128.86 
 
15.616 
 
130.12 14.70 1202 2477.0 0.331 
 
0.741 
 
 
 
 
WISCONSIN PRESEVATIVE  ERROR PERCENTAGE 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
Z  SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
PE% 
 
118.04 
 
19.665 
 
119.54 18.72 1190.5 2465.5 0.410 
 
0.6818 
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WISCONSIN NON-PRESEVATIVE  ERRORS 
 
TESTS CASES 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
Z  SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
NPE 
 
116.38 
 
11.96 
 
115.42 10.13 1237 2512.0 -0.090 
 
0.928 
 
 
 
 
 
WISCONSIN NON-PRESEVATIVE  ERROR PERCENTAGE 
 
TESTS CASES (n=50) 
CONTROL
S (n=50) MANN
WHIT
NEYU 
WILC
OXON
W 
Z  SIGNIFI
C ANT2 
TAILED 
  
MEAN 
 
SD 
 
MEAN SD 
NPE% 
 
110.66 
 
11.829 
 
109.92 11.02 1212 2487 -0.262 
 
0.794 
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WISCONSIN CLR 
 
TESTS CASES (n=50) 
CONTROLS 
(n=50) 
 
MANN 
WHIT 
NEYU 
WILC 
OXON
W 
 
 
Z 
 
SIGNIF 
2 
TAILED  
 
MEAN 
 
SD 
 
MEAN SD 
CLR 
 
50.52 
 
5.559 
 
50.14 4.738 1141 2416 
 
0.751 
 
0.453 
 
CLR% 
 
109.68 
 
12.005 
 
110.02 10.822 1209 2484 
 
0.283 
 
0.779 
 
CC 
 
5.08 
 
0.695 
 
5.14 0.670 1194 2469.0 
 
0.386 
 
.703 
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The scores  on  compar ison  of  WCST er rors  are ,  
Mann-whi tney  U 1222,  Wilcoxon W 2497.500 and Z 
score  i s  0 .193,  p  –  0 .849  ;  The  scores  on  compar ison  of  
WCST percent  e r rors  a re ,  Mann-whi tney  U 1177,  
Wilcoxon W 2452 and Z score  0 .503,  p  –  0 .617 ;  
s imi lar ly  for  WCST persevera t ive  response  the  scores  
a re ,  Mann-whi tney  U 1184,  Wilcoxon W 2459 and Z 
score  i s  0 .455  p  –  0 .652;  for  percent  persevera t ive  
response Mann-whi tney  U 1139,  Wilcoxon W 2414 and 
Z score  i s  0 .765,  p  –  0 .447.   
Al l  these  tes t s  d id  not  show s ta t i s t ica l ly  
s ignif icance  d i f ference  between the  two groups .   
The  scores  on  compar ison  of  WCST persevera t ive  
er rors  a re  Mann-whi tney  U 1201,  Wilcoxon W 2477 and 
Z score  0 .331,  p  –  0 .741 .  The  scores  for  WCST percent  
persevera t ive  er rors  are  Mann-whi tney  U 1190.5 ,  
Wilcoxon W 2465.5  and Z score  0 .410 p  –  0 .681.  Scores  
for  WCST non-persevera t ive  er rors  a re ,  Mann-whi tney  
U 1237,  Wilcoxon W 2512 and Z score  -0 .090 p  –  0 .928;  
for  WCST percent  non persevera t ive  er rors  ,  Mann-
whi tney  U 1212,  Wilcoxon W 2487 and Z score  -0 .262 p  
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–  0 .762;  a l l  the  tes t  scores  were  not  s ta t i s t ica l ly  
s ignif icant .  
The  compar ison  of  scores  for  conceptua l  leve l  
response Mann-whi tney  U 1141,  Wilcoxon W 2416,  Z  
score  -4 .947;  percent  conceptua l  leve l  response  Mann-
whi tney  U 105.000,  Wilcoxon W 570.000 ,  Z  score  
0 .751 p  –  0 .453 ;  ca tegor ies  comple ted ,  Mann-whi tney  
U 1189,  Wilcoxon W 2469.000 ,  Z  score  0 .386 p  –  
0 .703.   Al l  the  tes t  were  not  s ta t i s t ica l ly  s igni f icant .  
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DISCUSSION: 
The devas ta t ing  af fec t  of  type  2  d iabetes  
mel l i tus  on  card io-vascular ,  k idney,  re t ina l ,  and  
per iphera l  nerves  have  been  extens ive ly  s tudied  
and adequate ly  wel l  documented .  But ,  newer  
evidence  are  sugges t ing  tha t  o lder  adul t s  wi th  
d iabetes  mel l i tus  exhib i t  s igni f icant  impai rment  in  
p lanning ,  coordina t ing ,  sequencing ,  as  wel l  as  
moni tor ing  of  cogni t ive  opera t ions ,  which  are  the  
p i l la rs  of   execut ive  funct ion .  
Epidemiologica l  s tudies  sugges t  tha t  d iabetes  
mel l i tus  i s  a  s t ronger  r i sk  fac tor  for  Alzheimer  
d isease .  Recent  research  s tudies  fo l lowing la rge  
groups  over  many years  sugges t  tha t  adul t s  wi th  
type  2  d iabetes  have  a  h igher  r i sk  of  la te r  
developing  Alzheimer ′s ,  and  the  r i sk  ef fec ts  a re  
s t ronger  when d iabetes  occurs  mid- l i fe  than  in  la te  
l i fe .  
Thes  s tudy a imed a t  assess ing  execut ive  
funct ioning  in  type2 d iabetes  mel l i tus  pa t ien ts  
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aged be tween 40  -50  years  cont ro l led  for  fac tors  
tha t  a f fec t  cogni t ive  funct ioning ,  compared  to  
Non-diabet ic  cont ro ls .  Age group of  40-50 years  
was  taken mainly  to  avoid  any age  re la ted  
cogni t ive  def ic i t s .  Formal  educat ion  of  a t  leas t  8 th  
s tandard  was  appl ied  so  tha t  the  subjec ts  could  
unders tand the  tes t s  and  per form.   
In  the  d iabet ic  pa t ien ts ,  overa l l  dura t ion  of  
d isease  was  less  than  f ive  years .  They were  on  
regular  fo l low-up.  Thei r  b lood sugar  was  
cont ro l led  by  d ie t ,  exerc ise ,  and  ora l  
Hypoglycemic  drug  in  a l l  pa t ien ts .  In  20% of  
d iabet ic  pa t ients  insul in  was  a lso  requi red  to  
achieve .  The  d iabetes  mel l i tus  pa t ien t   were  a l l  
aware  of  the i r  chronic  medica l  condi t ion .  Hence  
they  ca l ibra ted  and t i t ra ted  the i r  personal  hea l th  
care  and checkup according  to  i t .  But  they  were  
not  in  any  way gross ly   infer ior  in  major  hea l th ,  
sensory ,  and  phys io-psychologica l  charac ter i s t ics .  
S imi lar  c r i te r ia  was  appl ied  for  se lec t ion  of  
cont ro l  group and both  groups  were  adminis te red  
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s t ruc tured  ques t ionnai res  to  ident i fy  and exclude  
the  presence  of  any psychia t r ic  d isease .  Subjec ts  
wi th  h is tory  of  any neurologica l  i l lness  or  
subs tance  dependence  were  exc luded to  remove any 
confounding ef fec ts .  The  soc io-demographic  da ta  
of  the  s tudy and cont ro l  groups  were  matched wi th  
respect  to  age ,  sex ,  educat ion  and occupat ion .
 Execut ive  Funct ion  was  tes ted  us ing  a  ba t te ry  
of  tes t  -  
a .  Forward  Digi t  span  
b .  Reverse  d ig i t  span  
c .  Let ter  f luency 
d .  Category  Fluency 
e .  Trai l  making tes t  A & B 
f .  Wiscons in  Card  Sor t ing  Tes t  
g .  Stroop  Tes t  
 
 On analys is  of   per formance   execut ive  
tes t  funct ion  ba t te ry ,  no  s igni f icant  d i f ference ,  
observed be tween the  two groups ,  and  the  d iabet ic  
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group had  an  equiva lent  MMSE score  compared  to  
cont ro l  group.  
The  overa l l  t rend of  d iabetes- re la ted  def ic i t s  
in  per formance(poor  scores) ,  d iscrepancy in  the  
resul t s  a re  not  uncommon (Ni lsson ,  2006) .  In  our  
s tudy we found tha t  here  was  no  s igni f icant  
d i f ference  be tween d iabet ic  and  non-diabet ic  group 
in  case  d ig i t  span,  verbal  f luency,  s t roop tes t  and  
WCST.   
There  was  a  s ta t i s t ica l ly  s igni f icant  
d i f ference   be tween case  and  cont ro l  group in  Tra i l  
Making Tes t .  There  was  average  d i f ference  of  8  
seconds  be tween d iabet ic  and non-  d iabet ics .   The  
St roop tes t  showed a  s imi lar  s lowing in  d iabet ics  
of  3  seconds  bot  not  s ta t i s t ica l ly  s igni f icant .  
Diabetes  mel l i tus  re la ted  s lowing in  a  number  of  
speed  based  tasks  were  observed  in  many previous  
s tudies .  Those  evalua t ing  bas ic  reac t ion  t ime or  
perceptua l  speed  are  the  most  a f fec ted .  
(Arvani takis ,  e ta l  2006;  Awad e t  a l . ,  2004;  
Fontbonne ,  e ta l  2001;  Mess ier  in  2005) .   
 
 98
The  d ig i t  span  tes t  d id  not  show much 
d i f ference  be tween case  and cont ro l  group.  The  
verba l  f luency was  a lso  wi th in  normal  l imi t  in  
d iabet ics  compared  to  the  non-diabet ics .  The  
Wiscons in  card  sor t ing  tes t  -  [WCST 
(persevera t ion) ,  B:  WCST (ca tegory)  and C:  WCST 
(conceptua l  responses) ]  a l so  d id  not  vary  
s ignif icant ly  be tween d iabet ic  group and non-
diabet ic  group.  The  d iabetes  mel l i tus  -  associ ted  
per formance  def ic i t s in  execut ive  funct ion  was  
observed in  some (but  not  a l l )  s tudies  (Awad e t  a l . ,  
2004;  Mess ier ,  2005;  Ryan  & Geckle ,  2000;  
S tewar t  & Liol i t sa ,  1999) .  I t  may be  because   
ofexecut ive  funct ions ,   involvement  in  mul t ip le  
undermining  processes  or  d imensions  (de  Fr ias ,  
Dixon,  & St rauss ,  2006;  Miyake ,  
Fre idman,Emerson,  Witzki ,  & Hower ter ,  2000) .  
Ni lsson  (2006) ,  sugges ted  not  a l l  aspec ts  of  
cogni t ion  may be  equal ly  or  co inc identa l ly  
af fec ted  by  Type 2  d iabetes ,  a t  leas t  in  re la t ive ly  
mi ld  to-modera te  cases .  Execut ive  Dysfunct ion  
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could  be  a t t r ibuted  to  d iabetes  mel l i tus  sever i ty , i t s  
neurologica l  sequelae  or  due  to  o ther  associa ted  
mul t ip le  co-morbid  condi t ions .  
Wong e ta l (2002)  showed tha t  d iabet ic  
re t inopathy  i s  independent ly  associa ted  wi th  poor  
cogni t ive  funct ioning .  Cerebra l  Micro-vascular  
d isease  may cont r ibute  to  cogni t ive  impai rment .  
Prospect ive  mul t icent r ic  and  mul t i -na t ional  s tudies  
l ike  LADIS or  randomized s tudies  such  as  
PROSPER highl ighted  d iabetes  as  an  independent  
r i sk  fac tor  for  cogni t ive  impai rment  in  e lder ly  
indiv iduals  over  70  years .  
Type2 Diabetes  mel l i tus  associa ted  
neurologica l  mechanisms i s  compounded by  many 
o ther  co-morbid  condi t ions  which  can ,  compound,  
confound ,as  wel l  as  exaggerate  and exacerbate  the   
Execut ive  dysfunct ion  due  to  d iabetes  mel l i tus .  
Impor tant  among these  assoc ia ted  co-morbid i t ies  
a re :  neurologica l  /  psychia t r ic  a f fec t ions ,  
hyper tens ion ,  card io-vascular  and  cerebro-vascular  
d iseases ,  as  wel l  as  drug usage . (e .g . ,  Arvani takis  
 
 100
e t  a l ,  2006;  Jacobson e t  a l .2007;  Rober tson  e t  
a l ,1986;  Vanhanen e t  a l . ,  1998;  van  Har ten  e t  a l . ,  
2007;  Xu,  Qiu ,  e t  a l ,  2004) .    
Hence ,  in  my s tudy we used  a  ser ies  of  
cogni t ive  and phys ica l  hea l th- re la ted  exclus ionary  
cr i te r ia  for  subjec t  se lec t ion  to  the  case   group.  
Our  s tudy group were  between 40  -50  years  age  
group,  wi th  a  dura t ion  of  d isease  less  than  or  equal  
to  f ive  years ,  wi thout  any  macro-vascular  
compl ica t ions .   This  s tudy group d idn’ t  show a  
s igni f icant  execut ive  dysfunct ion  compared  to  
previous   s tudies  probably  due  to  re la t ive ly  recent  
onse t  d isease  and a  younger  popula t ion  group.   My 
diabetes  mel l i tus  s tudr  group wi th  a   N-  50  i s  wel l  
wi th in  the  acceptable  range of  comparable  former  
neuropsychologica l  s tudies .  
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CONCLUSION: 
 Execut ive funct ioning in  pat ients  with  Type 2  
diabetes  mel l i tus  was comparable  to  that  of  control  group.  
Though Trai l  making tes t ,  showed a  s ta t is t ical  di f ference 
between diabet ics  and non-diabet ic ,  i t  was s t i l l  wi thin the 
normative Range for  the par t icular  age group.  Val idat ion 
of  these conclusion requires  a  larger  group and prospect ive 
longi tudinal  s tudy.  Future  fol low up assessment  is  
essent ial  to  see  how the Cognit ive  dysfunct ion would 
develop in  our  pat ients  over  a  per iod of  t ime and whether  
they wil l  a lso  develop problems in  their  execut ive 
funct ions and information processing abi l i t ies  as  
concluded by other  s tudies .  
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LIMITATIONS: 
 The study sample size in both cases and controls groups is low 
which might reduce the power of study. 
 This is a cross sectional study assessing the cognitive functioning 
which might bring about individual variations during one 
assessment. 
 Long term  glycemic control(HbA1c)  were not incorporated. 
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APPENDIX  1 
PROFORMA 
 
1. Name                 : 
2. Age 
3. Sex          : 
4. Occupation        : 
5. Marital status    :         Married / Unmarried 
6. Domicile           :         Rural / Urban 
7. Educational status:      Primary / secondary / degree 
8. Socio economic status: low / middle / high 
9. Religion : Hinduism / Christianity / Islam 
10. Relation to patient : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX  2 
PROFORMA-CLINICAL  CHARACTERISTICS  OF TYPE2 
DIABETES MELLITUS PATIENTS 
1.Name : 
2.Age of onset of illness :  
3.Duration of illness :  
4. Type of treatment :  
 Diet and Exercise 
 Diet And Exercise  + Oral Hypoglycemic Drugs 
 Diet And Exercise  + Oral Hypoglycemic Drugs + Insulin 
 Diet and Exercise + Insulin 
5. Presence of Complication: 
  
 
 
APPENDIX  3 
General Health Questionnaire: 
We want to know how your health has been in general over the last few weeks. 
Please read the questions below and each of the four possible answers. Circle 
the response that best applies to you. Thank you for answering all the questions. 
Have you recently: 
1. been able to concentrate on what you’re doing? 
better than usual same as usual less than usual much less than usual 
(0) (1) (2) (3) 
2. lost much sleep over worry? 
Not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
3. felt that you are playing a useful part in things? 
more so than usual same as usual less so than usual much less than usual 
(0) (1) (2) (3) 
4. felt capable of making decisions about things? 
more so than usual same as usual less than usual much less than usual 
(0) (1) (2) (3) 
5. felt constantly under strain? 
Not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
6. felt you couldn’t overcome your difficulties? 
Not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
7. been able to enjoy your normal day to day activities? 
more so than usual same as usual less so than usual much less than usual 
(0) (1) (2) (3) 
8. been able to face up to your problems? 
more so than usual same as usual less than usual much less than usual 
 
 
(0) (1) (2) (3) 
EHS M270: Work and Health Spring 2007 
20 
9. been feeling unhappy or depressed? 
not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
10. been losing confidence in yourself? 
not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
11. been thinking of yourself as a worthless person? 
not at all no more than usual rather more than usual much more than usual 
(0) (1) (2) (3) 
12. been feeling reasonably happy, all things considered? 
more so than usual same as usual less so than usual much less than usual 
(0) (1) (2) (3) 
EHS M270: Work and Health Spring 2007 
General Health Questionnaire Scoring 
Scoring – Likert Scale 0, 1, 2, 3 from left to right. 
12 items, 0 to 3 each item 
Score range 0 to 36. 
Scores vary by study population.1.  Scores about 11-12 typical. 2. Score >15 
evidence of distress 3. Score >20 suggests severe problems and psychological 
distress 
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APPENDIX 7 
Trail Marking Test B 
 
TIME: 
 
 
 
 
APPENDIX 8 
 
STROOP COLOUR TEST SCORING 
 
NAME: 
 
 
CARD 
 
NO. OF ERRORS 
TIME TAKEN(t) 
 
CARD I 
  
 
CARD II 
  
 
CARD III 
  
 
Stroop effect = t III – (t I + t II / 2) 
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